Processing 00000000.tx.1: Genetically Defined Forms of Diabetes in Children Simeon I. 

Phrase: "Genetically Defined Forms of Diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "in Children Simeon I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: Taylor and Elif Arioglu Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland 20892 Address correspondence and requests for reprints to: Simeon I. 

Phrase: "Taylor"

Phrase: "and"

Phrase: "Elif Arioglu Diabetes Branch,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1253959:Branch [Body Part, Organ, or Organ Component]
   812   C1881507:Branch [Chemical Viewed Structurally]
   812   C2700383:Branch [Plant]
   812   C2826234:BRANCH [Intellectual Product]

Phrase: "National Institute of Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Digestive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012238:Digestive [Organism Function]
  1000   C0012240:Digestive [Body System]

Phrase: "and"

Phrase: "Kidney Disease,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0022658:Kidney disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Bethesda,"

Phrase: "Maryland 20892 Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Simeon I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.3: Taylor, M.D., Ph.D., National Institutes of Health, Building 10, Room 9S-213, 10 Center Drive, Bethesda, Maryland 20892. 

Phrase: "Taylor,"

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ph.D.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1512022:Ph.D. [Intellectual Product]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Building"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1547706:Building [Functional Concept]
  1000   C1999269:Building [Manufactured Object]
   966 E C1707059:Build [Conceptual Entity]

Phrase: "10,"

Phrase: "Room 9S-213,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547703:Room [Spatial Concept]
   827   C1552123:9s [Body Part, Organ, or Organ Component]

Phrase: "10 Center Drive,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013126:Drive [Mental Process]

Phrase: "Bethesda,"

Phrase: "Maryland 20892."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024858:Maryland [Geographic Area]
Processing 00000000.tx.4: E-mail: Simeon_Taylor{at}nih.gov  Introduction Top Introduction Insulin Deficiency Insulin Resistance Conclusion References  ALTHOUGH type 1 diabetes has its highest incidence in the pediatric age range, there are also other forms of diabetes that affect children. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Simeon_Taylor{at}nih.gov  Introduction Top Introduction Insulin Deficiency Insulin Resistance Conclusion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   752   C1514811:Reference [Idea or Concept]
   752   C1706462:Reference [Conceptual Entity]

Phrase: "ALTHOUGH"

Phrase: "type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "has"

Phrase: "its highest incidence in the pediatric age range,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0021149:Incidence [Quantitative Concept]
   744   C0220856:incidence [Functional Concept]

Phrase: "there"

Phrase: "are"

Phrase: "also"

Phrase: "other forms of diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "children."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008059:Children [Age Group]
  1000   C0680063:Children [Family Group]
Processing 00000000.tx.5: From a clinical point of view, it is important to recognize these other forms of diabetes because of the important implications with respect to both prognosis and therapy. 

Phrase: "From a clinical point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "of view,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "recognize"

Phrase: "these other forms of diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "because of the important implications"

Phrase: "with respect to both prognosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033325:Prognosis [Health Care Activity]

Phrase: "and"

Phrase: "therapy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]
Processing 00000000.tx.6: In addition, these relatively uncommon forms of diabetes provide an instructive model for the pathophysiological mechanisms that cause diabetes. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "these relatively uncommon forms of diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an instructive model for the pathophysiological mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.7: Some syndromes are caused by insulin deficiency [e.g. maturity-onset type diabetes of the young (MODY)]. 

Phrase: "Some syndromes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039082:Syndromes [Disease or Syndrome]
  1000   C1558916:SYNDROMES [Finding]

Phrase: "are"

Phrase: "caused by insulin deficiency"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0011155:Deficiency [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1623416:deficiency [Qualitative Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "["

Phrase: "e.g. maturity-onset type diabetes of the young (MODY)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   860   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   860   C2984262:Maturity onset diabetes of the young [Functional Concept]
   784   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   764   C1320657:type diabetes [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]

Phrase: "]."
Processing 00000000.tx.8: Unlike patients with type 1 diabetes who exhibit near total absence of insulin due to autoimmune destruction of the  cell, MODY is characterized by a milder form of insulin deficiency caused by mutations in genes required for normal  cell function (1, 2, 3, 4, 5, 6). 

Phrase: "Unlike patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "who"

Phrase: "exhibit near total absence of insulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0015272:Exhibit [Intellectual Product]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "due to autoimmune destruction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1261381:Destruction [Therapeutic or Preventive Procedure]
   861   C1948029:Destruction [Activity]

Phrase: "of the  cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "MODY"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   910   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   910   C2984262:Maturity onset diabetes of the young [Functional Concept]
   804   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   778   C1320657:type diabetes [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]

Phrase: "is"

Phrase: "characterized by a milder form of insulin deficiency"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0011155:Deficiency [Functional Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0162429:Deficiency [Disease or Syndrome]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1623416:deficiency [Qualitative Concept]
   744   C1880022:Characterized [Activity]
   711   C2945599:Mild [Qualitative Concept]

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "required for normal  cell function"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   806   C0007613:Cell Function [Cell Function]
   806   C0007634:Normal cell [Cell]
           Cell
   806   C1268443:Normal cell [Cell]
   760   C0031843:function [Physiologic Function]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1269647:Cell [Cell]
   760   C1514873:Required [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1705273:Function [Intellectual Product]
   760   C1948049:Cell [Spatial Concept]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.9: However, not all cases of diabetes are caused by insulin deficiency. 

Phrase: "However,"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all cases of diabetes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "caused by insulin deficiency."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0011155:Deficiency [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1623416:deficiency [Qualitative Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.10: Indeed, some patients develop diabetes even though their  cells secrete sufficient insulin to achieve significant hyperinsulinemia (e.g. lipoatrophic diabetes and syndromes due to mutations in the insulin receptor gene) (7, 8, 9, 10).  

Phrase: "Indeed,"

Phrase: "some patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "develop"

Phrase: "diabetes even"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "though"

Phrase: "their  cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "sufficient insulin to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "achieve"

Phrase: "significant hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "("

Phrase: "e.g. lipoatrophic diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011859:Lipoatrophic Diabetes [Disease or Syndrome]
  1000   C0221032:lipoatrophic diabetes [Congenital Abnormality,Disease or Syndrome]
  1000   C1720860:LIPOATROPHIC DIABETES [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   789   C0023787:lipoatrophy [Disease or Syndrome]
   789   C1280433:Lipoatrophy [Disease or Syndrome]

Phrase: "and"

Phrase: "syndromes due to mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039082:Syndromes [Disease or Syndrome]
   770   C1558916:SYNDROMES [Finding]

Phrase: "in the insulin receptor gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1334133:Insulin Receptor Gene [Gene or Genome]
           INSULIN RECEPTOR
   913   C1337112:Insulin Gene [Gene or Genome]
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: ")"

Phrase: "(7,"

Phrase: "8,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.11: Insulin Deficiency Top Introduction Insulin Deficiency Insulin Resistance Conclusion References  MODY: clinical features MODY was originally defined by three diagnostic criteria (1): 1) onset at less than 25 yr of age; 

Phrase: "Insulin Deficiency Top Introduction Insulin Deficiency Insulin Resistance Conclusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C1707478:Conclusion [Idea or Concept]
   712   C0021655:Insulin Resistance [Pathologic Function]
   712   C2700570:INSULIN RESISTANCE [Gene or Genome]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "MODY"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   910   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   910   C2984262:Maturity onset diabetes of the young [Functional Concept]
   804   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   778   C1320657:type diabetes [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "clinical features MODY"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   860   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   860   C2984262:Maturity onset diabetes of the young [Functional Concept]
   784   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   764   C1320657:type diabetes [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]

Phrase: "was"

Phrase: "originally"

Phrase: "defined by three diagnostic criteria"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0679228:diagnostic criteria [Intellectual Product]
   760   C0011900:Diagnostic [Finding]
   760   C0205449:Three [Quantitative Concept]
   760   C0243161:criteria [Intellectual Product]
   760   C0348026:Diagnostic [Functional Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "onset at less"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332162:Onset [Qualitative Concept]

Phrase: "than 25 yr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439234:yr [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.12: 2) autosomal dominant inheritance; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "autosomal dominant inheritance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0443147:Autosomal dominant inheritance [Intellectual Product]
           Autosomal dominant
   913   C0678944:autosomal inheritance [Genetic Function]
   901   C0678942:dominant inheritance [Genetic Function]
   827   C0242538:Inheritance [Quantitative Concept]
   827   C0728826:Inheritance [Functional Concept]
   827   C1527180:Dominant [Functional Concept]

Phrase: ";"
Processing 00000000.tx.13: and 3) noninsulin-dependent physiology. 

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "noninsulin-dependent physiology."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0031842:Physiology [Biomedical Occupation or Discipline]
   827   C0031843:physiology [Physiologic Function]
   755 E C0205463:Physiologic [Functional Concept]
Processing 00000000.tx.14: However, recent progress has led to the identification of at least five genes that are responsible for causing MODY (2, 3, 4, 5, 6). 

Phrase: "However,"

Phrase: "recent progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1272688:progress [Functional Concept]
   861   C1280477:Progress [Functional Concept]

Phrase: "has"

Phrase: "led to the identification of"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "at least five genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "are"

Phrase: "responsible for causing MODY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1273518:Responsible [Finding]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.15: Thus, based on the locus of the mutation causing disease, the heterogeneous group of MODY patients can be subdivided into relatively homogeneous groups of patients with subtypes of MODY (see below). 

Phrase: "Thus,"

Phrase: "based on the locus of the mutation causing disease,"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   781   C2985434:Disease-causing Mutation [Cell or Molecular Dysfunction]
   745   C1314792:disease cause [Functional Concept]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0026882:Mutation [Genetic Function]
   742   C0678227:Causing [Functional Concept]
   742   C1527178:Based [Functional Concept]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
   742   C1705938:Based [Idea or Concept]
   742   C1708726:Locus [Gene or Genome]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0015127:cause [Functional Concept]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1524003:Cause [Conceptual Entity]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the heterogeneous group of MODY patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   736   C0441833:Group [Idea or Concept]
   736   C0687744:group [Population Group]
   736   C1257890:Group [Population Group]
   736   C1552516:Group [Health Care Related Organization]
   736   C1705428:Group [Conceptual Entity]
   736   C1705429:Group [Population Group]

Phrase: "can"

Phrase: "be"

Phrase: "subdivided into relatively homogeneous groups of patients"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1552839:groups [Idea or Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C1881065:Homogeneous [Qualitative Concept]

Phrase: "with subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449560:subtypes [Classification]

Phrase: "of MODY"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   842   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   812   C1320657:type diabetes [Finding]
   793   C0011847:Diabetes [Disease or Syndrome]
   793   C0011849:Diabetes [Disease or Syndrome]
   793   C0332162:Onset [Qualitative Concept]
   793   C0332239:Young [Temporal Concept]
   793   C0332285:Of [Spatial Concept]
   793   C0332307:Type [Qualitative Concept]
   793   C0449989:Maturity [Qualitative Concept]
   793   C0700597:Maturity [Temporal Concept]
   793   C1547052:*Type [Quantitative Concept]
   721 E C0205286:Mature [Temporal Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.16: Assignment to a specific subtype of MODY has important prognostic implications. 

Phrase: "Assignment to a specific subtype of MODY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1516050:Assignment [Functional Concept]

Phrase: "has"

Phrase: "important prognostic implications."
Processing 00000000.tx.17: For example, MODY2 is characterized by mild hyperglycemia that has onset early in childhood and is nonprogessive (11). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "MODY2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0342277:MODY2 [Disease or Syndrome]
  1000   C1841962:MODY2 [Disease or Syndrome]

Phrase: "is"

Phrase: "characterized by mild hyperglycemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020456:Hyperglycaemia [Disease or Syndrome]
   770   C1880022:Characterized [Activity]
   770   C2945599:Mild [Qualitative Concept]

Phrase: "that"

Phrase: "has"

Phrase: "onset early in childhood"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   916   C1851422:Onset in early childhood [Finding]
           Onset early childhood
   881   C1837352:Onset in childhood [Finding]
           Childhood onset
   819   C1833334:Early-onset [Finding]
   770   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "nonprogessive"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.18: Indeed, only half the patients have sufficient hyperglycemia to meet the criteria for diagnosis of diabetes. 

Phrase: "Indeed,"

Phrase: "only half"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]
   861   C2825407:Half [Quantitative Concept]

Phrase: "the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "sufficient hyperglycemia to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "meet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Meet [Idea or Concept]

Phrase: "the criteria for diagnosis of diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.19: As predicted by the mild degree of hyperglycemia, MODY2 does not carry a high risk of developing chronic complications of diabetes. 

Phrase: "As"

Phrase: "predicted by the mild degree of hyperglycemia,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0020456:Hyperglycaemia [Disease or Syndrome]
   748   C0441889:Degree [Qualitative Concept]
   748   C0449286:Degree [Quantitative Concept]
   748   C0542560:Degree [Intellectual Product]
   748   C0681842:Predicted [Idea or Concept]
   748   C1561545:degree [Quantitative Concept]
   748   C1882327:%{Predicted} [Quantitative Concept]
   748   C2348088:Degree [Quantitative Concept]
   748   C2945599:Mild [Qualitative Concept]

Phrase: "MODY2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0342277:MODY2 [Disease or Syndrome]
  1000   C1841962:MODY2 [Disease or Syndrome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "a high risk of developing chronic complications of diabetes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0332167:High risk of [Qualitative Concept]
           High Risk
   764   C3272283:High Risk [Finding]
   762   C1171304:diabetes risk [Quantitative Concept]
   742   C0035647:Risk [Qualitative Concept]
   742   C0205250:High [Qualitative Concept]
   742   C1299351:High [Qualitative Concept]
   742   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.20: In contrast, the degree of hyperglycemia and the risk of diabetic complications is much greater in MODY1, MODY3, and MODY5 (1). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the degree of hyperglycemia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "and"

Phrase: "the risk of diabetic complications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "is"

Phrase: "much greater in MODY1,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "MODY3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1838100:MODY3 [Disease or Syndrome]
  1000   C3273648:MODY3 [Gene or Genome]

Phrase: "and"

Phrase: "MODY5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0431693:MODY5 [Congenital Abnormality,Disease or Syndrome]
  1000   C1420636:MODY5 [Gene or Genome]
  1000   C2348633:MODY5 [Gene or Genome]
  1000   C3540897:MODY5 [Disease or Syndrome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: MODY4 seems to be intermediate in severity (5). 

Phrase: "MODY4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1826562:MODY4 [Gene or Genome]
  1000   C1833382:MODY4 [Disease or Syndrome]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "intermediate in severity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205103:Intermediate [Spatial Concept]
   790   C1550465:intermediate [Idea or Concept]
   790   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.22: Different authorities have published various estimates of the prevalence of the subtypes of MODY, but MODY2 and MODY3 are the most common, together accounting for up to 80% of cases. 

Phrase: "Different authorities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599437:authorities [Social Behavior]

Phrase: "have"

Phrase: "published various estimates of the prevalence of the subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0750572:estimates [Quantitative Concept]

Phrase: "of MODY,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   842   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   812   C1320657:type diabetes [Finding]
   793   C0011847:Diabetes [Disease or Syndrome]
   793   C0011849:Diabetes [Disease or Syndrome]
   793   C0332162:Onset [Qualitative Concept]
   793   C0332239:Young [Temporal Concept]
   793   C0332285:Of [Spatial Concept]
   793   C0332307:Type [Qualitative Concept]
   793   C0449989:Maturity [Qualitative Concept]
   793   C0700597:Maturity [Temporal Concept]
   793   C1547052:*Type [Quantitative Concept]
   721 E C0205286:Mature [Temporal Concept]

Phrase: "but"

Phrase: "MODY2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0342277:MODY2 [Disease or Syndrome]
  1000   C1841962:MODY2 [Disease or Syndrome]

Phrase: "and"

Phrase: "MODY3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1838100:MODY3 [Disease or Syndrome]
  1000   C3273648:MODY3 [Gene or Genome]

Phrase: "are"

Phrase: "the most common, together"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205214:Common [Quantitative Concept]
   827   C0205393:Most [Quantitative Concept]
   827   C1522138:Common [Functional Concept]
   827   C1883357:Together [Qualitative Concept]
   827   C3245511:common [Intellectual Product]

Phrase: "accounting for"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C0000938:Accounting [Occupational Activity]
   799 E C1551359:account [Idea or Concept]
   799 E C2741673:Account # [Clinical Attribute]
   799 E C2981730:Account [Classification]

Phrase: "up to 80%"

Phrase: "of cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.23: Like MODY, the syndrome due to mutations in the insulin gene has early onset and is transmitted with autosomal dominant inheritance (12). 

Phrase: "Like MODY,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   842   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   812   C1320657:type diabetes [Finding]
   793   C0011847:Diabetes [Disease or Syndrome]
   793   C0011849:Diabetes [Disease or Syndrome]
   793   C0332162:Onset [Qualitative Concept]
   793   C0332239:Young [Temporal Concept]
   793   C0332307:Type [Qualitative Concept]
   793   C0449989:Maturity [Qualitative Concept]
   793   C0700597:Maturity [Temporal Concept]
   793   C0870814:Like [Mental Process]
   793   C1547052:*Type [Quantitative Concept]
   721 E C0205286:Mature [Temporal Concept]

Phrase: "the syndrome due to mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1857276:THE SYNDROME [Disease or Syndrome]
   760   C0039082:Syndrome [Disease or Syndrome]

Phrase: "in the insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "early onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1833334:Early-onset [Finding]
   861   C0332162:Onset [Qualitative Concept]
   861   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "is"

Phrase: "transmitted with autosomal dominant inheritance"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0443147:Autosomal dominant inheritance [Intellectual Product]
           Autosomal dominant
   806   C0678942:dominant inheritance [Genetic Function]
   797   C0678944:autosomal inheritance [Genetic Function]
   760   C0242538:Inheritance [Quantitative Concept]
   760   C0242781:Transmitted [Pathologic Function]
   760   C0332289:transmitted [Functional Concept]
   760   C0596142:autosomal [Cell Component]
   760   C0728826:Inheritance [Functional Concept]
   760   C1521797:Transmitted [Natural Phenomenon or Process]
   760   C1527180:Dominant [Functional Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.24: Although heterozygosity for a mutation in the insulin gene does not necessarily cause diabetes, it seems to be a genetic risk factor that predisposes to the development of insulin deficiency and diabetes in some patients. 

Phrase: "Although"

Phrase: "heterozygosity for a mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygosity [Organism Attribute]

Phrase: "in the insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "does"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "it"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a genetic risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035648:Risk factor [Quantitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   734   C1517512:Genetic Risk [Quantitative Concept]

Phrase: "that"

Phrase: "predisposes to the development of insulin deficiency"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0011155:Deficiency [Functional Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1623416:deficiency [Qualitative Concept]

Phrase: "and"

Phrase: "diabetes in some patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.25: However, unlike MODY, patients with mutations in the insulin gene have elevated levels of circulating immunoreactive insulin because of the accumulation of abnormal molecules with markedly reduced biological activity. 

Phrase: "However,"

Phrase: "unlike MODY, patients"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   891   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   891   C2984262:Maturity onset diabetes of the young [Functional Concept]
   834   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   807   C1320657:type diabetes [Finding]
   791   C0011847:Diabetes [Disease or Syndrome]
   791   C0011849:Diabetes [Disease or Syndrome]
   791   C0030705:Patients [Patient or Disabled Group]
   791   C0332162:Onset [Qualitative Concept]
   791   C0332239:Young [Temporal Concept]
   791   C0332307:Type [Qualitative Concept]
   791   C0449989:Maturity [Qualitative Concept]
   791   C0700597:Maturity [Temporal Concept]
   791   C1547052:*Type [Quantitative Concept]
   720 E C0205286:Mature [Temporal Concept]

Phrase: "with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "have"

Phrase: "elevated levels of circulating immunoreactive insulin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0202098:insulin levels [Laboratory Procedure]
   783   C0428405:insulin levels [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "because of the accumulation"

Phrase: "of abnormal molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "with markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "biological activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205177:Activity [Functional Concept]
   861   C0205460:biological [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.26: Diabetes due to mutations in mitochondrial DNA is transmitted with matrilineal inheritance and incomplete penetrance. 

Phrase: "Diabetes due to mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in mitochondrial DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "is"

Phrase: "transmitted with matrilineal inheritance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0242538:Inheritance [Quantitative Concept]
   770   C0242781:Transmitted [Pathologic Function]
   770   C0332289:transmitted [Functional Concept]
   770   C0728826:Inheritance [Functional Concept]
   770   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "incomplete penetrance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1836598:Incomplete penetrance [Finding]
   861   C0524899:Penetrance [Quantitative Concept]
Processing 00000000.tx.27: In pedigrees where the mutation is transmitted to daughters (who can transmit the mutation to their own children), the pattern can resemble autosomal inheritance. 

Phrase: "In pedigrees where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030761:pedigrees [Intellectual Product]

Phrase: "the mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "transmitted to daughters"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011011:Daughters [Family Group]
   790   C0242781:Transmitted [Pathologic Function]
   790   C0332289:transmitted [Functional Concept]
   790   C1521797:Transmitted [Natural Phenomenon or Process]
   756 E C1610715:Daughter [Intellectual Product]

Phrase: "("

Phrase: "who"

Phrase: "can"

Phrase: "transmit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332289:transmit [Functional Concept]

Phrase: "the mutation to their own children"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: ","

Phrase: "the pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "can"

Phrase: "resemble"

Phrase: "autosomal inheritance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678944:autosomal inheritance [Genetic Function]
   861   C0242538:Inheritance [Quantitative Concept]
   861   C0728826:Inheritance [Functional Concept]
Processing 00000000.tx.28: Furthermore, because this syndrome may lead to early-onset diabetes, it may occasionally be confused with MODY. 

Phrase: "Furthermore,"

Phrase: "because"

Phrase: "this syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039082:Syndrome [Disease or Syndrome]

Phrase: "may"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to early-onset diabetes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1833334:Early-onset [Finding]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]

Phrase: "it"

Phrase: "may"

Phrase: "occasionally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Occasionally [Temporal Concept]

Phrase: "be"

Phrase: "confused with MODY."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   860   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   860   C2984262:Maturity onset diabetes of the young [Functional Concept]
   784   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   764   C1320657:type diabetes [Finding]
   742   C0009676:Confused [Mental or Behavioral Dysfunction]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0332162:Onset [Qualitative Concept]
   742   C0332239:Young [Temporal Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0449989:Maturity [Qualitative Concept]
   742   C0700597:Maturity [Temporal Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1547301:Confused [Intellectual Product]
Processing 00000000.tx.29: However, unlike MODY, diabetes due to mutations in mitochondrial DNA is often associated with other clinical features, such as deafness (13, 14, 15). 

Phrase: "However,"

Phrase: "unlike MODY, diabetes"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   891   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   891   C2984262:Maturity onset diabetes of the young [Functional Concept]
   834   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   807   C1320657:type diabetes [Finding]
   791   C0011847:Diabetes [Disease or Syndrome]
   791   C0011849:Diabetes [Disease or Syndrome]
   791   C0332162:Onset [Qualitative Concept]
   791   C0332239:Young [Temporal Concept]
   791   C0332307:Type [Qualitative Concept]
   791   C0449989:Maturity [Qualitative Concept]
   791   C0700597:Maturity [Temporal Concept]
   791   C1547052:*Type [Quantitative Concept]
   720 E C0205286:Mature [Temporal Concept]

Phrase: "due to mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in mitochondrial DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "associated with other clinical features,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205210:Clinical [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726   C1521970:Feature [Qualitative Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "such as deafness"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0011053:Deafness [Disease or Syndrome]
  1000   C0018772:deafness [Finding]
  1000   C0581883:Deafness [Disease or Syndrome]
   928 E C0525064:DEAF [Patient or Disabled Group]
   928 E C1547302:Deaf [Intellectual Product]

Phrase: "(13,"

Phrase: "14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.30: Wolframs syndrome is another genetic form of diabetes mellitus with onset in childhood, but this syndrome has multiple features that distinguish it from MODY: autosomal recessive inheritance and association with optic atrophy, diabetes insipidus, and deafness. 

Phrase: "Wolframs syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "is"

Phrase: "another genetic form of diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "with onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "in childhood,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231335:Childhood [Temporal Concept]

Phrase: "but"

Phrase: "this syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039082:Syndrome [Disease or Syndrome]

Phrase: "has"

Phrase: "multiple features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "that"

Phrase: "distinguish"

Phrase: "it from MODY"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   860   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   860   C2984262:Maturity onset diabetes of the young [Functional Concept]
   784   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   764   C1320657:type diabetes [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0332162:Onset [Qualitative Concept]
   742   C0332239:Young [Temporal Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0449989:Maturity [Qualitative Concept]
   742   C0700597:Maturity [Temporal Concept]
   742   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "autosomal recessive inheritance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441748:Autosomal recessive inheritance [Intellectual Product]
           Autosomal recessive
   913   C0678944:autosomal inheritance [Genetic Function]
   901   C0678943:recessive inheritance [Genetic Function]
   827   C0242538:Inheritance [Quantitative Concept]
   827   C0728826:Inheritance [Functional Concept]

Phrase: "and"

Phrase: "association with optic atrophy,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "diabetes insipidus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011848:Diabetes Insipidus [Disease or Syndrome]
  1000   C0687720:diabetes insipidus [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "deafness."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0011053:Deafness [Disease or Syndrome]
  1000   C0018772:deafness [Finding]
  1000   C0581883:Deafness [Disease or Syndrome]
   928 E C0525064:DEAF [Patient or Disabled Group]
   928 E C1547302:Deaf [Intellectual Product]
Processing 00000000.tx.31: The gene for Wolframs has been mapped to chromosome 4p and has recently been cloned (16). 

Phrase: "The gene for Wolframs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "mapped to chromosome 4p"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   802   C0814036:chromosome map [Intellectual Product]
   770   C0008633:Chromosome [Cell Component]
   770   C0814184:4P's [Intellectual Product]
   770   C1521758:4p [Nucleotide Sequence]
   770   C1552219:4p [Body Part, Organ, or Organ Component]
   737   C0024779:Map [Manufactured Object]
   737   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.32: MODY: molecular genetics Glucokinase catalyzes the first step in intracellular glucose metabolism (i.e. phosphorylation of glucose) (17, 18). 

Phrase: "MODY"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   910   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   910   C2984262:Maturity onset diabetes of the young [Functional Concept]
   804   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   778   C1320657:type diabetes [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "molecular genetics Glucokinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415014:GLUCOKINASE [Gene or Genome]
   734   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]

Phrase: "catalyzes"

Phrase: "the first step in intracellular glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596620:glucose metabolism [Molecular Function]
   799   C0025519:Metabolism [Organism Function]
   799   C0025520:metabolism [Functional Concept]

Phrase: "(i.e. phosphorylation of glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: ")"

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.33: Whereas hexokinases are capable of phosphorylating all hexoses, glucokinase is specific for glucose. 

Phrase: "Whereas"

Phrase: "hexokinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0019472:HEXOKINASE [Amino Acid, Peptide, or Protein,Enzyme]
   966   C0523692:Hexokinase [Laboratory Procedure]

Phrase: "are"

Phrase: "capable of phosphorylating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "all hexoses,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019494:Hexoses [Carbohydrate]

Phrase: "glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "is"

Phrase: "specific for glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]
Processing 00000000.tx.34: In addition, whereas hexokinases have such low Km that they are saturated at physiological concentrations of glucose, glucokinase has a Km of 10 mM so that the flux through the enzyme is sensitive to changes in the glucose concentration within the the physiological range. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "whereas"

Phrase: "hexokinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0019472:HEXOKINASE [Amino Acid, Peptide, or Protein,Enzyme]
   966   C0523692:Hexokinase [Laboratory Procedure]

Phrase: "have"

Phrase: "such low Km"

Phrase: "that"

Phrase: "they"

Phrase: "are"

Phrase: "saturated at physiological concentrations of glucose,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0427743:concentrations glucose [Laboratory Procedure]
   783   C1287281:concentrations glucose [Laboratory or Test Result]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0205463:Physiological [Functional Concept]
   753   C0522534:Saturated [Phenomenon or Process]
   753   C1705188:SATURATED [Quantitative Concept]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "has"

Phrase: "a Km of 10 mM"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the flux through the enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "sensitive to changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332324:Sensitive to [Functional Concept]
           Sensitive
   790   C1550474:sensitive [Idea or Concept]

Phrase: "in the glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "within the"

Phrase: "the physiological range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]
Processing 00000000.tx.35: Furthermore, glucokinase is specifically expressed in hepatocytes and pancreatic  cells, where it plays a crucial role in glucose metabolism. 

Phrase: "Furthermore,"

Phrase: "glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "is"

Phrase: "specifically"

Phrase: "expressed in hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0227525:Hepatocytes [Cell]
   756 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "pancreatic  cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "where"

Phrase: "it"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a crucial role in glucose metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.36: Abundant evidence has demonstrated that glucokinase is a necessary component in the  cell glucose-sensor. 

Phrase: "Abundant evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "has"

Phrase: "demonstrated"

Phrase: "that glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "is"

Phrase: "a necessary component in the  cell glucose-sensor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0243092:Cell component [Cell Component]
   767   C1178969:Cell Component [Cell Component]
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.37: Indeed, the fact that inactivating mutations in the glucokinase gene lead to impaired insulin secretion and diabetes (MODY2) provides one of the most convincing pieces of evidence proving the role of glucokinase in regulating insulin secretion (3). 

Phrase: "Indeed,"

Phrase: "the fact"

Phrase: "that inactivating mutations in the glucokinase gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "lead to impaired insulin secretion"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(MODY2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0342277:MODY2 [Disease or Syndrome]
  1000   C1841962:MODY2 [Disease or Syndrome]

Phrase: ")"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "one of the most convincing pieces of evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "proving"

Phrase: "the role of glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "regulating"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.38: This conclusion is further reinforced by the observation that an activating mutation in glucokinase led to hyperinsulinism and hypoglycemia (19). 

Phrase: "This conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "reinforced by the observation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that"

Phrase: "an activating mutation in glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "led to hyperinsulinism"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0020459:Hyperinsulinism [Disease or Syndrome]
   790   C1708698:LED [Manufactured Object]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C1522538:Lead [Functional Concept]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "hypoglycemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020615:Hypoglycaemia [Disease or Syndrome]
   928 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.39: Consistent with the dominant inheritance in this syndrome, patients with MODY2 have inherited one mutant allele of the glucokinase gene. 

Phrase: "Consistent with the dominant inheritance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in this syndrome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039082:Syndrome [Disease or Syndrome]

Phrase: "patients with MODY2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "inherited one mutant allele of the glucokinase gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0002085:Allele [Gene or Genome]
           allelic gene
Processing 00000000.tx.40: Furthermore, studies in an animal model have demonstrated that selective knock-out of glucokinase expression in the  cell can cause diabetes, suggesting that impaired insulin secretion is the major mechanism whereby these mutations cause diabetes (20, 21). 

Phrase: "Furthermore,"

Phrase: "studies in an animal model"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0599779:Animal Model [Animal]
   797   C0683949:Animal Study [Animal]
   760   C0003062:Animal [Animal]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C2603343:Study [Research Activity]
   760   C3161035:Model [Intellectual Product]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that selective knock-out of glucokinase expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0560617:knock out [Injury or Poisoning]
   778   C1522225:Knock-out [Experimental Model of Disease]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]

Phrase: "in the  cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that impaired insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "the major mechanism whereby"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.41: Nevertheless, there is some evidence that the defect in hepatic glucokinase may also contribute to the pathophysiology of the disease. 

Phrase: "Nevertheless,"

Phrase: "there"

Phrase: "is"

Phrase: "some evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the defect in hepatic glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "may"

Phrase: "also"

Phrase: "contribute to the pathophysiology of the disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0012634:Disease [Disease or Syndrome]
   748   C0031847:pathophysiology [Functional Concept]
   748   C0277785:Pathophysiology [Qualitative Concept]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.42: The remaining four subtypes of MODY are caused by mutations in the genes encoding transcription factors that regulate the expression of genes in the  cell (22): hepatocyte nuclear factor-4 (HNF-4) in MODY1 (2), HNF-1 in MODY 3 (4), insulin promoter factor-1 (IPF-1) in MODY4 (5), and HNF-1 in MODY5 (6). 

Phrase: "The remaining four subtypes of MODY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0449560:subtypes [Classification]

Phrase: "are"

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "regulate"

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the  cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "(22"

Phrase: ")"

Phrase: ":"

Phrase: "hepatocyte nuclear factor-4 (HNF-4) in MODY1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   833   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0227525:Hepatocyte [Cell]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "HNF-1 in MODY 3"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   863   C1838100:Maturity-Onset Diabetes of the Young, Type 3 [Disease or Syndrome]
   863   C1852093:Maturity-Onset Diabetes of the Young, Type 1 [Disease or Syndrome]
   831   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   831   C2984262:Maturity onset diabetes of the young [Functional Concept]
   772   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   770   C0011854:Diabetes Type 1 [Disease or Syndrome]
   756   C1320657:type diabetes [Finding]
   754   C0441729:Type 1 [Classification]
   754   C0441731:Type 3 [Classification]
   754   C1414685:HNF-3 [Gene or Genome]
   754   C3538717:HNF-3 [Gene or Genome]
   738   C0011847:Diabetes [Disease or Syndrome]
   738   C0011849:Diabetes [Disease or Syndrome]
   738   C0332162:Onset [Qualitative Concept]
   738   C0332239:Young [Temporal Concept]
   738   C0332307:Type [Qualitative Concept]
   738   C0449989:Maturity [Qualitative Concept]
   738   C0700597:Maturity [Temporal Concept]
   738   C1547052:*Type [Quantitative Concept]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "insulin promoter factor-1 (IPF-1) in MODY4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1521761:Factor [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "HNF-1 in MODY5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0431693:MODY5 [Congenital Abnormality,Disease or Syndrome]
   770   C1420636:MODY5 [Gene or Genome]
   770   C2348633:MODY5 [Gene or Genome]
   770   C3540897:MODY5 [Disease or Syndrome]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.43: IPF-1 contributes to the regulation of the insulin gene as well as additional genes that are important for  cell function. 

Phrase: "IPF-1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "contributes to the regulation of the insulin gene"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1337112:Insulin Gene [Gene or Genome]
   767   C0017263:Gene Regulation [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1880177:Contribute [Activity]

Phrase: "as well as"

Phrase: "additional genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "are"

Phrase: "important for  cell function."
Processing 00000000.tx.44: Indeed, homozygosity for inactivating mutations of IPF-1 leads to pancreatic agenesis (23). 

Phrase: "Indeed,"

Phrase: "homozygosity for inactivating mutations of IPF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0019904:Homozygosity [Organism Attribute]

Phrase: "leads to pancreatic agenesis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0000846:Agenesis [Functional Concept]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C0181586:leads [Medical Device]
   770   C0332907:Agenesis [Congenital Abnormality]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.45: [In contrast, heterozygosity for a mutation in IPF-1 causes MODY (5).] 

Phrase: "["

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "heterozygosity for a mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygosity [Organism Attribute]

Phrase: "in IPF-1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "MODY"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   910   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   910   C2984262:Maturity onset diabetes of the young [Functional Concept]
   804   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   778   C1320657:type diabetes [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."

Phrase: "]"
Processing 00000000.tx.46: As suggested by their names, the family of HNF also plays a role in regulation of genes expressed in the liver. 

Phrase: "As"

Phrase: "suggested by their names,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027365:Name [Intellectual Product]
   770   C1547383:Name [Intellectual Product]
   737   C1705535:Suggest [Idea or Concept]

Phrase: "the family of HNF also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015576:Family [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in regulation of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "expressed in the liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.47: Although it is likely that mutations in HNF-1, -1 and -4 cause diabetes because they impair insulin secretion, it is possible that metabolic defects within the hepatocyte also contribute to disease pathogenesis.  

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that mutations in HNF-1, -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and -"

Phrase: "4 cause diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "because"

Phrase: "they"

Phrase: "impair"

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that metabolic defects within the hepatocyte also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0243067:defects [Functional Concept]
   714 E C1457869:Defect [Functional Concept]
   714 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "contribute to disease pathogenesis."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.48: Insulin Resistance Top Introduction Insulin Deficiency Insulin Resistance Conclusion References  Clinical features Two clinical features are commonly observed in patients with extreme insulin resistance, regardless of the pathogenetic mechanism causing the disease: acanthosis nigricans and hyperandrogenism (7, 8, 9, 24). 

Phrase: "Insulin Resistance Top Introduction Insulin Deficiency Insulin Resistance Conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C1707478:Conclusion [Idea or Concept]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Clinical features Two clinical features"

Phrase: "are"

Phrase: "commonly"

Phrase: "observed in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441672:Observed [Functional Concept]

Phrase: "with extreme insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regardless of the pathogenetic mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "acanthosis nigricans"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0000889:Acanthosis Nigricans [Disease or Syndrome]
   861   C0221270:Acanthosis [Pathologic Function]
   789 E C0333991:Acanthotic [Functional Concept]

Phrase: "and"

Phrase: "hyperandrogenism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206081:Hyperandrogenism [Disease or Syndrome]

Phrase: "(7,"

Phrase: "8,"

Phrase: "9,"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.49: Acanthosis nigricans is a hyperkeratotic, hyperpigmented skin lesion located primarily in skin folds such as the axillae and antecubital fossae (Fig. 1). 

Phrase: "Acanthosis nigricans"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0000889:Acanthosis Nigricans [Disease or Syndrome]
   861   C0221270:Acanthosis [Pathologic Function]
   789 E C0333991:Acanthotic [Functional Concept]

Phrase: "is"

Phrase: "a hyperkeratotic,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0334012:Hyperkeratotic [Functional Concept]
   928 E C0870082:HYPERKERATOSES [Disease or Syndrome]

Phrase: "hyperpigmented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333615:Hyperpigmented [Functional Concept]

Phrase: "skin lesion"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0037284:Skin lesion [Disease or Syndrome]
   861   C0221198:Lesion [Finding]
   861   C0444099:Skin [Body Substance]
   861   C1123023:Skin [Body System]
   861   C1278993:Skin [Body System]
   861   C1546698:Lesion [Intellectual Product]
   805 E C0221912:Cutaneous [Spatial Concept]
   805 E C0221928:Dermal [Qualitative Concept]
   805 E C1522447:Cutaneous [Functional Concept]
   738 E C0011646:Dermis [Tissue]

Phrase: "located"

Phrase: "primarily in skin folds"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   799   C1446851:Skin fold [Laboratory Procedure]
   770   C0332462:Fold [Spatial Concept]
   770   C0444099:Skin [Body Substance]
   770   C1123023:Skin [Body System]
   770   C1278993:Skin [Body System]
   770   C1880834:FOLD [Phenomenon or Process]
   715 E C0221912:Cutaneous [Spatial Concept]
   715 E C0221928:Dermal [Qualitative Concept]
   715 E C1522447:Cutaneous [Functional Concept]

Phrase: "such as the axillae"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0004454:Axilla [Body Location or Region]
   966   C1283835:Axilla [Body Location or Region]
   966   C1284953:Axilla [Body Location or Region]

Phrase: "and"

Phrase: "antecubital fossae"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0446523:Antecubital Fossa [Body Location or Region]
   861   C1549091:Antecubital [Body Part, Organ, or Organ Component]
   827   C0325079:Fossa [Mammal]
   827   C0836913:Fossa [Body Space or Junction]
   827   C0936029:Fossa [Mammal]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.50: Hyperandrogenism results from hypersecretion of androgens by the ovaries (7, 24). 

Phrase: "Hyperandrogenism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206081:Hyperandrogenism [Disease or Syndrome]

Phrase: "results from hypersecretion of androgens"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0002844:Androgens [Hormone,Pharmacologic Substance]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   726 E C3536949:Androgen [Pharmacologic Substance]

Phrase: "by the ovaries"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0029939:Ovaries [Body Part, Organ, or Organ Component]
  1000   C0227898:ovaries [Body Part, Organ, or Organ Component]
   966 E C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "(7,"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.51: Clinically, the elevated levels of testosterone are manifested as a syndrome of polycystic ovaries, oligomenorrhea, hirsutism, and, sometimes, virilization. 

Phrase: "Clinically,"

Phrase: "the elevated levels of testosterone"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C0428412:testosterone level [Laboratory or Test Result]
   781   C0523912:Testosterone level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "manifested as a syndrome of polycystic ovaries,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   788   C0032460:Polycystic Ovary Syndrome [Disease or Syndrome]
           Polycystic ovaries
   748   C0029939:Ovaries [Body Part, Organ, or Organ Component]
   748   C0039082:Syndrome [Disease or Syndrome]
   748   C0205319:manifested [Functional Concept]
   748   C0227898:ovaries [Body Part, Organ, or Organ Component]
   748   C1280444:manifested [Qualitative Concept]
   748   C3273362:Polycystic [Qualitative Concept]
   714 E C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "oligomenorrhea,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028949:Oligomenorrhea [Pathologic Function]

Phrase: "hirsutism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019572:Hirsutism [Finding]

Phrase: "and"

Phrase: ","

Phrase: "sometimes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "virilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042755:Virilisation [Sign or Symptom]
Processing 00000000.tx.52: Several lines of evidence suggest that both acanthosis nigricans and hyperandrogenism are caused by hyperinsulinemiapresumably exerting "toxic" effects on the skin and ovaries. 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both acanthosis nigricans"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0000889:Acanthosis Nigricans [Disease or Syndrome]
   861   C0221270:Acanthosis [Pathologic Function]
   789 E C0333991:Acanthotic [Functional Concept]

Phrase: "and"

Phrase: "hyperandrogenism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206081:Hyperandrogenism [Disease or Syndrome]

Phrase: "are"

Phrase: "caused by hyperinsulinemiapresumably exerting ""toxic"" effects"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   756   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   753   C0015264:exerting [Organism Function]
   753   C1280500:effects [Qualitative Concept]
   753   C1407029:Toxic [Qualitative Concept]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on the skin"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0444099:Skin [Body Substance]
  1000   C1123023:Skin [Body System]
  1000   C1278993:Skin [Body System]
   944 E C0221912:Cutaneous [Spatial Concept]
   944 E C0221928:Dermal [Qualitative Concept]
   944 E C1522447:Cutaneous [Functional Concept]
   877 E C0011646:Dermis [Tissue]

Phrase: "and"

Phrase: "ovaries."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0029939:Ovaries [Body Part, Organ, or Organ Component]
  1000   C0227898:ovaries [Body Part, Organ, or Organ Component]
   966 E C1278992:Ovary [Body Part, Organ, or Organ Component]
Processing 00000000.tx.53: For example, when patients with type B insulin resistance enter remission because of a decrease in the titer of autoantibodies directed against the insulin receptor, this results in amelioriation (even disappearance) of acanthosis nigricans and hyperandrogenism. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "when"

Phrase: "patients with type B insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1550335:Patient type [Classification]
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "remission because of a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0544452:Remission [Finding]
   760   C0687702:remission [Neoplastic Process]

Phrase: "in the titer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475208:Titer [Quantitative Concept]

Phrase: "of autoantibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "directed against the insulin receptor,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   806   C1334133:INSULIN RECEPTOR [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "this results in amelioriation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "(even disappearance"

Phrase: ")"

Phrase: "of acanthosis nigricans"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0000889:Acanthosis Nigricans [Disease or Syndrome]
   861   C0221270:Acanthosis [Pathologic Function]
   789 E C0333991:Acanthotic [Functional Concept]

Phrase: "and"

Phrase: "hyperandrogenism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206081:Hyperandrogenism [Disease or Syndrome]
Processing 00000000.tx.54: Similarly, in insulin-resistant patients with polycystic ovarian syndrome, administration of drugs such as metformin and thiazolidinediones leads to a decrease in plasma insulin levels and a concomitant amelioriation in hyperandrogenism (25, 26). 

Phrase: "Similarly,"

Phrase: "in insulin-resistant patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "with polycystic ovarian syndrome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032460:Polycystic Ovarian Syndrome [Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "administration of drugs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   858   C3469597:administration drugs [Health Care Activity]
   841 E C0150270:Drug administration [Health Care Activity]
   790   C0001554:Administration [Occupational Activity]
   790   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "such as metformin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025598:Metformin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "thiazolidinediones"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "leads to a decrease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   966   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "a concomitant amelioriation in hyperandrogenism"

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.55: Although the mechanism whereby hyperinsulinemia elicits these toxic effects has not been elucidated, it is likely not to be mediated by conventional insulin receptors inasmuch as these are functionally impaired as the result of inactivating mutations. 

Phrase: "Although"

Phrase: "the mechanism whereby hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "these toxic effects"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   861   C1280500:effects [Qualitative Concept]
   861   C1407029:Toxic [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "elucidated"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "mediated by conventional insulin receptors"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   773 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0439858:Conventional [Qualitative Concept]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "inasmuch as"

Phrase: "these"

Phrase: "are"

Phrase: "functionally"

Phrase: "impaired as the result of inactivating mutations."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0026882:Mutations [Genetic Function]
   748   C0221099:Impaired [Functional Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.56: View larger version (96K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(96K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.57: Photograph of patient with Rabson-Mendenhall syndrome.  

Phrase: "Photograph of patient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0431056:Photography of patient [Diagnostic Procedure]
   790   C0441468:photograph [Manufactured Object]

Phrase: "with Rabson-Mendenhall syndrome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0271695:Rabson-Mendenhall Syndrome [Disease or Syndrome]
           Mendenhall Syndrome
   827   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.58: In addition to the clinical signs that the various syndromes share in common, distinct syndromes are characterized by the presence or absence of specific features. 

Phrase: "In addition to the clinical signs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C3540840:CLINICAL SIGNS [Finding]
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "that"

Phrase: "the various syndromes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039082:Syndromes [Disease or Syndrome]
   861   C1558916:SYNDROMES [Finding]

Phrase: "share in common, distinct syndromes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039082:Syndromes [Disease or Syndrome]
   760   C0205214:Common [Quantitative Concept]
   760   C0237876:Share [Social Behavior]
   760   C1522138:Common [Functional Concept]
   760   C1558916:SYNDROMES [Finding]
   760   C3245511:common [Intellectual Product]

Phrase: "are"

Phrase: "characterized by the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1880022:Characterized [Activity]

Phrase: "or"

Phrase: "absence of specific features."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.59: For example, there are at least three clinical syndromes caused by mutations in the insulin receptor gene. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "there"

Phrase: "are at least three clinical syndromes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0221444:clinical syndromes [Classification]
   753   C0039082:Syndromes [Disease or Syndrome]
   753   C0205210:Clinical [Qualitative Concept]
   753   C0205449:Three [Quantitative Concept]
   753   C1551058:Are [Quantitative Concept]
   753   C1558916:SYNDROMES [Finding]

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the insulin receptor gene."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1334133:Insulin Receptor Gene [Gene or Genome]
           INSULIN RECEPTOR
   913   C1337112:Insulin Gene [Gene or Genome]
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
Processing 00000000.tx.60: Type A insulin resistance is defined by the triad of insulin resistance, acanthosis nigricans, and hyperandrogenism in the absence of obesity or lipoatrophy (27). 

Phrase: "Type A insulin resistance"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0342336:Type A insulin resistance [Disease or Syndrome]
   861   C0021655:Insulin Resistance [Pathologic Function]
   861   C2700570:INSULIN RESISTANCE [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0237834:Resistance [Mental Process]
   812   C1514892:Resistance [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   741 E C0332325:Resistant [Functional Concept]
   741 E C1550464:resistent [Idea or Concept]
   741 E C2827757:RESISTANT [Laboratory or Test Result]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "defined by the triad of insulin resistance,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0076994:triad [Biomedical or Dental Material,Organic Chemical]
   748   C0237834:Resistance [Mental Process]
   748   C1179122:triad [Cell Component]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1704788:Defined [Conceptual Entity]
   748   C3539106:Defined [Intellectual Product]

Phrase: "acanthosis nigricans,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0000889:Acanthosis Nigricans [Disease or Syndrome]
   861   C0221270:Acanthosis [Pathologic Function]
   789 E C0333991:Acanthotic [Functional Concept]

Phrase: "and"

Phrase: "hyperandrogenism in the absence of obesity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0206081:Hyperandrogenism [Disease or Syndrome]

Phrase: "or"

Phrase: "lipoatrophy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023787:lipoatrophy [Disease or Syndrome]
  1000   C1280433:Lipoatrophy [Disease or Syndrome]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.61: Patients with leprechaunism have multiple abnormalities, including intrauterine growth retardation, fasting hypoglycemia, and death within the first 12 yr of life (Fig. 2) (28, 29, 30). 

Phrase: "Patients with leprechaunism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "multiple abnormalities,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0000772:Abnormalities, Multiple [Congenital Abnormality]
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "intrauterine growth retardation,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0015934:Intrauterine Growth Retardation [Pathologic Function]
   913   C1386048:Intrauterine retardation [Pathologic Function]
   901   C0151686:Growth retardation [Pathologic Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0694756:Intrauterine [Body Space or Junction]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "fasting hypoglycemia,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0271708:Fasting Hypoglycemia [Disease or Syndrome]
   861   C0015663:Fasting [Finding]
   861   C0020615:Hypoglycaemia [Disease or Syndrome]
   861   C1550565:fasting [Intellectual Product]
   827 E C0456962:Fast [Qualitative Concept]
   789 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "and"

Phrase: "death within the first 12 yr of life"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0011065:Death [Organism Function]
   744   C1306577:Death, NOS [Finding]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(28,"

Phrase: "29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.62: Interestingly, patients with leprechaunism are reported to exhibit striking degrees of  cell hyperplasia. 

Phrase: "Interestingly,"

Phrase: "patients with leprechaunism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "are"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "striking degrees of  cell hyperplasia."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0449286:degrees [Quantitative Concept]
   760   C0542560:degrees [Intellectual Product]
   726 E C0441889:Degree [Qualitative Concept]
   726 E C1561545:degree [Quantitative Concept]
   726 E C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.63: Thus, near-total absence of insulin receptors does not impair the ability of human  cells to become hyperplastic, a reaction that can be rationalized as an attempt to compensate for severe insulin resistance. 

Phrase: "Thus,"

Phrase: "near-total absence of insulin receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impair"

Phrase: "the ability of human  cells to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "become"

Phrase: "hyperplastic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020507:Hyperplastic [Pathologic Function]

Phrase: "a reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "rationalized as an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1516084:Attempt [Event]

Phrase: "compensate for severe insulin resistance."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205082:Severe [Qualitative Concept]
   760   C0205432:compensate [Qualitative Concept]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.64: The Rabson-Mendenhall syndrome is associated with short stature, protruberant abdomen, and abnormalities of teeth and nails (Fig. 3); 

Phrase: "The Rabson-Mendenhall syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0271695:Rabson-Mendenhall Syndrome [Disease or Syndrome]
           Mendenhall Syndrome
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "is"

Phrase: "associated with short stature,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   833   C0013336:Short stature [Congenital Abnormality,Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0349588:Short stature [Finding]
   770   C0424639:Stature [Finding]
   770   C1282927:short [Qualitative Concept]
   770   C1806781:Short [Quantitative Concept]
   770   C1868676:STATURE [Finding]
   770   C2350002:Short [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "protruberant abdomen,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1856511:Protruberant abdomen [Finding]
   861   C0000726:Abdomen [Body Location or Region]
   861   C0230168:Abdomen [Body Location or Region]
   861   C1281594:Abdomen [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "abnormalities of teeth"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   858   C0040427:Teeth Abnormalities [Congenital Abnormality]
   822 E C0262444:Dental abnormalities [Finding]
   816 E C0858654:Abnormal teeth [Anatomical Abnormality]
   790   C0000768:Abnormalities [Congenital Abnormality]
   790   C0000769:abnormalities [Functional Concept]
   756 E C1704258:Abnormality [Finding]
   706 E C0205161:Abnormal [Qualitative Concept]
   706 E C2347472:% Abnormal [Quantitative Concept]
   706 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "and"

Phrase: "nails"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0027342:Nails [Body Part, Organ, or Organ Component]
   966 E C3538766:NAIL [Gene or Genome]
   900 E C0030578:Paronychia [Disease or Syndrome]
   900 E C1075202:Paronychia [Plant]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.65: pineal hyperplasia was a characteristic in the original description of this syndrome (31). 

Phrase: "pineal hyperplasia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020507:Hyperplasia [Pathologic Function]

Phrase: "was"

Phrase: "a characteristic in the original description of this syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1521970:Characteristic [Qualitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.66: In addition to genetic defects in insulin receptor function, there is an autoimmune form of insulin resistance due to autoantibodies to the insulin receptor (type B insulin resistance) (27). 

Phrase: "In addition to genetic defects"
Meta Candidates (Total=22; Excluded=17; Pruned=0; Remaining=5)
   972   C0000768:Birth Defects [Congenital Abnormality]
   972   C0220810:birth defects [Functional Concept]
   955 E C1737329:Birth defect [Congenital Abnormality]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0243067:defects [Functional Concept]
   861   C0314603:Genetic [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "in insulin receptor function,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0920644:receptor function [Molecular Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "there"

Phrase: "is"

Phrase: "an autoimmune form of insulin resistance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "due to autoantibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "to the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(type B insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   861   C0021655:Insulin Resistance [Pathologic Function]
   861   C2700570:INSULIN RESISTANCE [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0237834:Resistance [Mental Process]
   812   C1514892:Resistance [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   741 E C0332325:Resistant [Functional Concept]
   741 E C1550464:resistent [Idea or Concept]
   741 E C2827757:RESISTANT [Laboratory or Test Result]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.67: Although this syndrome has been reported in the pediatric age range, most of the patients have onset during adulthood. 

Phrase: "Although"

Phrase: "this syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039082:Syndrome [Disease or Syndrome]

Phrase: "has"

Phrase: "been"

Phrase: "reported in the pediatric age range,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   783   C0804405:Age - Reported [Clinical Attribute]
   753   C0001779:Age [Organism Attribute]
   753   C0030755:paediatric [Biomedical Occupation or Discipline]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1514721:Range [Quantitative Concept]
   753   C1521725:Pediatric [Qualitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3496591:Reported [Clinical Attribute]
   753   C3542016:Range [Intellectual Product]
   719 E C3273238:Report [Intellectual Product]

Phrase: "most of the patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205393:Most [Quantitative Concept]

Phrase: "have"

Phrase: "onset during adulthood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.68: View larger version (126K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(126K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.69: Photograph of patient with leprechaunism.  

Phrase: "Photograph of patient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0431056:Photography of patient [Diagnostic Procedure]
   790   C0441468:photograph [Manufactured Object]

Phrase: "with leprechaunism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0265344:Leprechaunism [Disease or Syndrome]
Processing 00000000.tx.70: View larger version (71K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(71K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.71: Photograph of patient with congenital generalized lipoatrophy (Seip-Berardinelli syndrome).  

Phrase: "Photograph of patient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0431056:Photography of patient [Diagnostic Procedure]
   790   C0441468:photograph [Manufactured Object]

Phrase: "with congenital generalized lipoatrophy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C3151447:Generalized lipoatrophy [Finding]
   827   C0023787:lipoatrophy [Disease or Syndrome]
   827   C1280433:Lipoatrophy [Disease or Syndrome]

Phrase: "(Seip-Berardinelli syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0221032:Seip's syndrome [Congenital Abnormality,Disease or Syndrome]
           Berardinelli's syndrome
   913   C1720863:Seip Syndrome [Congenital Abnormality,Disease or Syndrome]
           Berardinelli Syndrome
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.72: Lipoatrophic diabetes, another clinical syndrome associated with insulin resistance, is characterized by a paucity of subcutaneous fat, hypertriglyceridemia, and hepatic steatosis. 

Phrase: "Lipoatrophic diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011859:Lipoatrophic Diabetes [Disease or Syndrome]
  1000   C0221032:lipoatrophic diabetes [Congenital Abnormality,Disease or Syndrome]
  1000   C1720860:LIPOATROPHIC DIABETES [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   789   C0023787:lipoatrophy [Disease or Syndrome]
   789   C1280433:Lipoatrophy [Disease or Syndrome]

Phrase: "another clinical syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221444:clinical syndrome [Classification]
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "associated with insulin resistance,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "is"

Phrase: "characterized by a paucity of subcutaneous fat,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0222331:Subcutaneous Fat [Tissue]
   748   C0424612:FAT [Organism Attribute]
   748   C0443315:subcutaneous [Spatial Concept]
   748   C1880022:Characterized [Activity]

Phrase: "hypertriglyceridemia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020557:Hypertriglyceridaemia [Finding]
  1000   C1522137:Hypertriglyceridemia [Finding]

Phrase: "and"

Phrase: "hepatic steatosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015695:hepatic steatosis [Disease or Syndrome]
  1000   C2711227:Hepatic steatosis [Disease or Syndrome]
   861   C0152254:Steatosis [Pathologic Function]
   861   C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.73: Although the mutations causing genetic forms of lipoatrophic diabetes have not yet been identified, current evidence suggests that insulin resistance is secondary to the lipoatrophy and there may not be a primary genetic defect in the insulin action pathway (32, 33). 

Phrase: "Although"

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "genetic forms of lipoatrophic diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "current evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "secondary to the lipoatrophy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0175668:Secondary to [Temporal Concept]
           Secondary
   770   C0027627:secondary [Neoplastic Process]
   770   C0205436:Secondary [Quantitative Concept]

Phrase: "and"

Phrase: "there"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "a primary genetic defect in the insulin action pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0314603:Genetic [Functional Concept]
   742   C1457869:Defect [Functional Concept]
   742   C1861101:DEFECT [Disease or Syndrome]
   736   C0000768:Birth Defect [Congenital Abnormality]
   736   C1737329:Birth defect [Congenital Abnormality]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.74: The genes causing two forms of the lipoatrophy have been mapped: an autosomal recessive form of congenital, generalized lipoatrophy (Seip-Berardinelli syndrome; Figs. 3 and 4) to chromosome 9q34 (34), and an autosomal dominant form of partial (face-sparing) lipodystrophy with onset during adolescence (Dunnigans syndrome; Figs. 4 and 5) to chromosome 1q2122 (35). 

Phrase: "The genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "two forms of the lipoatrophy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "mapped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0024779:Map [Manufactured Object]
   966   C1706473:Map [Conceptual Entity]

Phrase: ":"

Phrase: "an autosomal recessive form of congenital, generalized lipoatrophy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "(Seip-Berardinelli syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0221032:Seip's syndrome [Congenital Abnormality,Disease or Syndrome]
           Berardinelli's syndrome
   913   C1720863:Seip Syndrome [Congenital Abnormality,Disease or Syndrome]
           Berardinelli Syndrome
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "; Figs. 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "to chromosome 9q34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1515529:9q34 [Cell Component]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "an autosomal dominant form of partial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "(face-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015450:Face [Body Location or Region]
  1000   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "sparing"

Phrase: ")"

Phrase: "lipodystrophy with onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023787:Lipodystrophy [Disease or Syndrome]

Phrase: "during adolescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001578:Adolescence [Age Group]
   928 E C0205653:Adolescent [Age Group]

Phrase: "(Dunnigans syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1720860:Dunnigan Syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "; Figs. 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "to chromosome 1q2122"

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.75: In addition to the genetic forms of lipoatrophy, there are also syndromes that are believed to have autoimmune pathogenesis inasmuch as they are associated with well-defined autoimmune diseases, such as juvenile dermatomyositis. 

Phrase: "In addition to the genetic forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "of lipoatrophy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023787:lipoatrophy [Disease or Syndrome]
  1000   C1280433:Lipoatrophy [Disease or Syndrome]

Phrase: "there"

Phrase: "are"

Phrase: "also syndromes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039082:Syndromes [Disease or Syndrome]
   861   C1558916:SYNDROMES [Finding]

Phrase: "that"

Phrase: "are"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "autoimmune pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]

Phrase: "inasmuch as"

Phrase: "they"

Phrase: "are"

Phrase: "associated with well-defined autoimmune diseases,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0004364:Autoimmune Diseases [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0442825:Well defined [Qualitative Concept]
   767   C0243083:associated disease [Pathologic Function]
   753   C0012634:Diseases [Disease or Syndrome]
   753   C0205170:Well [Qualitative Concept]
   753   C0443146:Autoimmune [Pathologic Function]
   753   C1704788:Defined [Conceptual Entity]
   753   C3146287:Well [Manufactured Object]
   753   C3539106:Defined [Intellectual Product]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "such as juvenile dermatomyositis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0263666:juvenile dermatomyositis [Disease or Syndrome]
  1000   C2931785:Juvenile dermatomyositis [Disease or Syndrome]
   861   C0011633:Dermatomyositis [Disease or Syndrome]
   861   C0221056:dermatomyositis [Disease or Syndrome]
   861   C3146221:Juvenile [Age Group]
Processing 00000000.tx.76: View larger version (133K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(133K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.77: Magnetic resonance imaging of the mid-thigh region of patients with lipoatrophy. 

Phrase: "Magnetic resonance imaging of the mid-thigh region of patients"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   824   C0412713:Magnetic resonance imaging of thigh [Diagnostic Procedure]
   782   C0024485:Magnetic Resonance Imaging [Diagnostic Procedure]
   782   C1552358:Magnetic Resonance Imaging [Professional or Occupational Group]
   760   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   760   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   760   C1551403:Magnetic resonance [Laboratory Procedure]
   739   C0011923:Imaging [Diagnostic Procedure]
   739   C0024488:Magnetic [Occupation or Discipline]
   739   C0079595:Imaging [Diagnostic Procedure]
   739   C0231881:Resonance [Finding]
   739   C0459800:resonance [Natural Phenomenon or Process]
   739   C0563532:magnetic [Natural Phenomenon or Process]
   739   C0684213:Resonance [Qualitative Concept]
   706 E C1704254:Image [Intellectual Product]
   706 E C1704922:Image [Entity]
   706 E C3542466:Image [Intellectual Product]

Phrase: "with lipoatrophy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023787:lipoatrophy [Disease or Syndrome]
  1000   C1280433:Lipoatrophy [Disease or Syndrome]
Processing 00000000.tx.78: A, A normal 42-yr-old woman with a body mass index of 24 kg/m2. 

Phrase: "A,"

Phrase: "A normal 42-yr-old woman with a body mass index"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0043210:Woman [Population Group]

Phrase: "of 24 kg/m2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456689:kg/m2 [Quantitative Concept]
   827   C0457242:m2 [Quantitative Concept]
Processing 00000000.tx.79: The normal individual demonstrates both sc adipose tissue (a circumferential band encircling the thigh) and deep adipose tissue located between muscle bundles. 

Phrase: "The normal individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027361:Individual [Population Group]
   861   C0237401:Individual [Human]

Phrase: "demonstrates"

Phrase: "both sc adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]

Phrase: "("

Phrase: "a circumferential band encircling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205113:Encircling [Spatial Concept]

Phrase: "the thigh"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039866:Thigh [Body Location or Region]
  1000   C1281586:Thigh [Body Part, Organ, or Organ Component]
   944 E C0015811:Femoral [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and"

Phrase: "deep adipose tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1525423:Deep tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]

Phrase: "located between muscle bundles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0504095:bundles muscle [Body Part, Organ, or Organ Component]
   770   C0026845:Muscle [Tissue]
Processing 00000000.tx.80: B, A 37-yr-old woman with Dunnigans syndrome. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "A 37-yr-old woman with Dunnigans syndrome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0043210:Woman [Population Group]
Processing 00000000.tx.81: This shows a marked diminution in the sc fat, but relative preservation of deeper fat. 

Phrase: "This"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a marked diminution in the sc fat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332511:Diminution [Qualitative Concept]

Phrase: "but"

Phrase: "relative preservation of deeper fat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033085:Preservation [Laboratory Procedure]
   760   C1514402:Preservation [Laboratory Procedure]
Processing 00000000.tx.82: C, a 29-yr-old woman with Seip-Berardinelli syndrome. 

Phrase: "C,"

Phrase: "a 29-yr-old woman with Seip-Berardinelli syndrome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0043210:Woman [Population Group]
Processing 00000000.tx.83: This patient shows near total absence of both compartments of adipose tissue, but the brightness of the muscle density is indicative of increased triglyceride content in muscle tissue.  

Phrase: "This patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "shows near total absence of both compartments of adipose tissue,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   760   C0001527:Adipose tissue [Tissue]
   757   C2983684:Total Tissue [Body Substance]
   739   C0040300:Tissue [Tissue]
   739   C0332197:absence [Quantitative Concept]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C1185625:Compartments [Body Space or Junction]
   739   C1382196:Compartments [Natural Phenomenon or Process]
   739   C1547282:Show [Intellectual Product]
   739   C1547928:Tissue [Intellectual Product]
   739   C1689985:Absence [Anatomical Abnormality]
   706 E C2986730:Compartment [Spatial Concept]

Phrase: "but"

Phrase: "the brightness of the muscle density"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678578:Brightness [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "indicative of increased triglyceride content"

Phrase: "in muscle tissue."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0026845:Muscle tissue [Tissue]
           Muscle
  1000   C2328219:Muscle tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.84: View larger version (118K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(118K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.85: Photograph of patient with face-sparing lipoatrophy (Dunnigans syndrome). 

Phrase: "Photograph of patient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0431056:Photography of patient [Diagnostic Procedure]
   790   C0441468:photograph [Manufactured Object]

Phrase: "with face-sparing lipoatrophy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0023787:lipoatrophy [Disease or Syndrome]
   827   C1280433:Lipoatrophy [Disease or Syndrome]

Phrase: "(Dunnigans syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1720860:Dunnigan Syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.86: There is marked decrease in sc adipose tissue in the legs. 

Phrase: "There"

Phrase: "is"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "decrease in sc adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0001527:Adipose tissue [Tissue]
   760   C0040300:Tissue [Tissue]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "in the legs."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1140621:Legs [Body Location or Region]
   966 E C0023216:Leg [Body Location or Region]
   966 E C1285009:Leg [Body Location or Region]
Processing 00000000.tx.87: Please note that this patient has undergone plastic surgery to achieve this normal facial appearance; 

Phrase: "Please"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "this patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "has"

Phrase: "undergone plastic surgery to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0038911:Surgery, Plastic [Biomedical Occupation or Discipline]
   861   C0677616:Plastic surgery, NOS [Therapeutic or Preventive Procedure]
   812   C0032167:Plastic [Substance]
   812   C0038894:Surgery [Biomedical Occupation or Discipline]
   812   C0038895:surgery [Functional Concept]
   812   C0543467:Surgery [Health Care Activity]

Phrase: "achieve"

Phrase: "this normal facial appearance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0332441:Normal appearance [Finding]
   913   C1271005:Normal appearance [Finding]
   901   C0282631:Facial appearance [Organism Attribute]
   827   C0233426:Appearance [Organism Attribute]
   827   C0700364:Appearance [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.88: before surgery, she had a marked increase in the fat in her face and neck.  

Phrase: "before surgery,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038894:Surgery [Biomedical Occupation or Discipline]
  1000   C0038895:surgery [Functional Concept]
  1000   C0543467:Surgery [Health Care Activity]

Phrase: "she"

Phrase: "had"

Phrase: "a marked increase in the fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in her face"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015450:Face [Body Location or Region]
  1000   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "neck."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0027530:Neck [Body Location or Region]
  1000   C1281592:Neck [Body Part, Organ, or Organ Component]
   944 E C0205064:Cervical [Spatial Concept]
Processing 00000000.tx.89: Molecular genetics Numerous (>70) mutations have been identified in the insulin receptor gene in various insulin-resistant patients. 

Phrase: "Molecular genetics"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "Numerous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439064:Numerous [Quantitative Concept]

Phrase: "("

Phrase: ">70"

Phrase: ")"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "identified in the insulin receptor gene"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C1334133:Insulin Receptor Gene [Gene or Genome]
           INSULIN RECEPTOR
   790   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   790   C1335671:Receptor Gene [Gene or Genome]
   783   C1337112:Insulin Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205396:Identified [Qualitative Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in various insulin-resistant patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.90: The mutations can be classified based on the mechanisms whereby they impair receptor function (8, 9, 10). 

Phrase: "The mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "be"

Phrase: "classified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008902:Classified [Classification]

Phrase: "based on the mechanisms whereby"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0441712:Mechanisms [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1706376:Mechanism [Manufactured Object]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "they"

Phrase: "impair"

Phrase: "receptor function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0920644:receptor function [Molecular Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(8,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.91: In some cases, the mutations decrease the number of receptors expressed on the cell surface [e.g. by decreasing the rate of receptor biosynthesis (class 1), accelerating the rate of receptor degradation (class 5), or inhibiting the transport of receptors to the plasma membrane (class 2)]. 

Phrase: "In some cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the number of receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "expressed on the cell surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "["

Phrase: "e.g."

Phrase: "by decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the rate of receptor biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "(class 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441885:Class 1 [Classification]
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: ")"

Phrase: ","

Phrase: "accelerating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0521110:accelerate [Functional Concept]

Phrase: "the rate of receptor degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "(class 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0457166:Class 5 [Intellectual Product]
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "the transport of receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "to the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(class 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441886:Class 2 [Intellectual Product]
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.92: In addition, some mutations impair the intrinsic function of the receptor [e.g. by decreasing the affinity of insulin binding (class 3) or inactivating receptor tyrosine kinase activity (class 4)]. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "some mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "impair"

Phrase: "the intrinsic function of the receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0920644:function receptor [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "["

Phrase: "e.g."

Phrase: "by decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the affinity of insulin binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "(class 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441887:Class 3 [Intellectual Product]
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "inactivating receptor tyrosine kinase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C1152633:receptor activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "(class 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441888:Class 4 [Intellectual Product]
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.93: Leprechaunism and the Rabson-Mendenhall syndrome are both transmitted with autosomal recessive patterns of inheritance; 

Phrase: "Leprechaunism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0265344:Leprechaunism [Disease or Syndrome]

Phrase: "and"

Phrase: "the Rabson-Mendenhall syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0271695:Rabson-Mendenhall Syndrome [Disease or Syndrome]
           Mendenhall Syndrome
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "are"

Phrase: "both"

Phrase: "transmitted with autosomal recessive patterns of inheritance"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   804   C0441748:Autosomal recessive inheritance [Intellectual Product]
           Autosomal recessive
   774   C0678943:recessive inheritance [Genetic Function]
   774   C0678944:autosomal inheritance [Genetic Function]
   774   C1136375:Inheritance Patterns [Genetic Function]
   748   C0242538:Inheritance [Quantitative Concept]
   748   C0242781:Transmitted [Pathologic Function]
   748   C0332289:transmitted [Functional Concept]
   748   C0449774:Patterns [Spatial Concept]
   748   C0596142:autosomal [Cell Component]
   748   C0728826:Inheritance [Functional Concept]
   748   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.94: affected individuals have inherited two inactivating mutations in the insulin receptor gene (36, 37, 38). 

Phrase: "affected individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "have"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "two inactivating mutations in the insulin receptor gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(36,"

Phrase: "37,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.95: There are two forms of type A insulin resistance: a severe form with autosomal recessive inheritance (39) and a milder form with autosomal dominant inheritance, most commonly caused by dominant negative mutations in the tyrosine kinase domain of the insulin receptor (40, 41). 

Phrase: "There"

Phrase: "are"

Phrase: "two forms of type A insulin resistance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   789   C3463805:Type of Form [Intellectual Product]
           form type
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: ":"

Phrase: "a severe form with autosomal recessive inheritance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "(39"

Phrase: ")"

Phrase: "and"

Phrase: "a milder form with autosomal dominant inheritance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "most commonly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "caused by dominant negative mutations"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   845   C1512032:Dominant-Negative Mutation [Cell or Molecular Dysfunction]
           Dominant Negative
   760   C0026882:Mutations [Genetic Function]
   760   C0205160:Negative [Qualitative Concept]
   760   C1513916:Negative [Finding]
   760   C1527180:Dominant [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the tyrosine kinase domain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1519724:Tyrosine Kinase Domain [Amino Acid Sequence]
   901   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.96: Among patients who have inherited two mutant alleles of the insulin receptor gene, it is not entirely clear why different patients develop different clinical syndromes. 

Phrase: "Among patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "have"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "two mutant alleles of the insulin receptor gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Alleles [Gene or Genome]

Phrase: "it"

Phrase: "is"

Phrase: "not entirely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "why different patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "develop"

Phrase: "different clinical syndromes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0221444:clinical syndromes [Classification]
   827   C0039082:Syndromes [Disease or Syndrome]
   827   C1558916:SYNDROMES [Finding]
Processing 00000000.tx.97: At least two different mechanisms have been proposed to correlate phenotype with genotype (8, 9, 42). 

Phrase: "At least two different mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate"

Phrase: "phenotype with genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0678920:genotype phenotype [Organism Attribute]
   790   C0031437:Phenotype [Organism Attribute]
   790   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(8,"

Phrase: "9,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.98: First, the severity of the defect in receptor function seems to correlate with the severity of the clinical syndrome, with the most severe mutations causing leprechaunism and less severe mutations causing type A insulin resistance. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the severity of the defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439793:Severity [Qualitative Concept]
   760   C2983285:Severity [Intellectual Product]

Phrase: "in receptor function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0920644:receptor function [Molecular Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with the severity of the clinical syndrome,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0221444:clinical syndrome [Classification]
   744   C0039082:Syndrome [Disease or Syndrome]
   744   C0205210:Clinical [Qualitative Concept]
   744   C0439793:Severity [Qualitative Concept]
   744   C2983285:Severity [Intellectual Product]

Phrase: "with the most severe mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "leprechaunism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0265344:Leprechaunism [Disease or Syndrome]

Phrase: "and"

Phrase: "less severe mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "type A insulin resistance."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0342336:Type A insulin resistance [Disease or Syndrome]
   861   C0021655:Insulin Resistance [Pathologic Function]
   861   C2700570:INSULIN RESISTANCE [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0237834:Resistance [Mental Process]
   812   C1514892:Resistance [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   741 E C0332325:Resistant [Functional Concept]
   741 E C1550464:resistent [Idea or Concept]
   741 E C2827757:RESISTANT [Laboratory or Test Result]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.99: The Rabson-Mendenhall syndrome is associated with defects that are intermediate in severity. 

Phrase: "The Rabson-Mendenhall syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0271695:Rabson-Mendenhall Syndrome [Disease or Syndrome]
           Mendenhall Syndrome
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "is"

Phrase: "associated with defects"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0243067:defects [Functional Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1457869:Defect [Functional Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   756 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "that"

Phrase: "are"

Phrase: "intermediate in severity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205103:Intermediate [Spatial Concept]
   790   C1550465:intermediate [Idea or Concept]
   790   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.100: Second, differences in genetic background (i.e. genotypes at other loci) may modulate the severity of the clinical syndrome. 

Phrase: "Second, differences in genetic background"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "(i.e. genotypes at other loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017431:Genotypes [Organism Attribute]

Phrase: ")"

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the severity of the clinical syndrome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439793:Severity [Qualitative Concept]
   753   C2983285:Severity [Intellectual Product]
Processing 00000000.tx.101: Class 1, decreased rate of receptor biosynthesis.

Phrase: "Class 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441885:Class 1 [Classification]
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "decreased rate of receptor biosynthesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.102: Several genetic defects can interfere with receptor biosynthesis. 

Phrase: "Several genetic defects"
Meta Candidates (Total=22; Excluded=17; Pruned=0; Remaining=5)
   873   C0000768:Birth Defects [Congenital Abnormality]
   873   C0220810:birth defects [Functional Concept]
   856 E C1737329:Birth defect [Congenital Abnormality]
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0243067:defects [Functional Concept]
   827   C0314603:Genetic [Functional Concept]
   793 E C1457869:Defect [Functional Concept]
   793 E C1861101:DEFECT [Disease or Syndrome]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "can"

Phrase: "interfere with receptor biosynthesis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1819634:receptor biosynthesis [Molecular Function]
   770   C0005572:biosynthesis [Functional Concept]
   770   C0220781:Biosynthesis [Biologic Function]
   770   C0521102:Interfere [Qualitative Concept]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.103: In one patient with leprechaunism, there was a total deletion of the insulin receptor gene (43). 

Phrase: "In one patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with leprechaunism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0265344:Leprechaunism [Disease or Syndrome]

Phrase: "there"

Phrase: "was"

Phrase: "a total deletion of the insulin receptor gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0017260:Gene Deletion [Genetic Function]
   767   C1442161:Gene Deletion [Cell or Molecular Dysfunction]
           Deletion
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.104: In several patients, there appear to be regulatory mutations that decrease the level of insulin receptor messenger RNA without altering the protein coding sequence of the gene (37). 

Phrase: "In several patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "there"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "regulatory mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the level of insulin receptor messenger RNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0202098:Insulin level [Laboratory Procedure]
   774   C0428405:insulin level [Laboratory or Test Result]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "without altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the protein coding sequence of the gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0079941:Protein Coding Sequence [Gene or Genome]
           Coding Sequence
   774   C0002518:Protein Sequence [Amino Acid Sequence]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.105: Finally, various premature chain termination mutations can lead to the synthesis of truncated receptors that are essentially inactive (36, 37, 38). 

Phrase: "Finally,"

Phrase: "various premature chain termination mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   877   C0544885:Premature Termination Mutation [Cell or Molecular Dysfunction]
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "lead to the synthesis of truncated receptors"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   757   C1819634:receptor synthesis [Molecular Function]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0220781:synthesis [Biologic Function]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1883254:Synthesis [Activity]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   738 E C3494280:Synthetic Receptors [Organic Chemical,Receptor]

Phrase: "that"

Phrase: "are"

Phrase: "essentially inactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205254:Inactive [Qualitative Concept]

Phrase: "(36,"

Phrase: "37,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.106: Class 2, impaired transport of receptors to the plasma membrane.

Phrase: "Class 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441886:Class 2 [Intellectual Product]
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "impaired transport of receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "to the plasma membrane."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.107: Some mutations appear to prevent folding of receptors into their normal conformations. 

Phrase: "Some mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "folding of receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "into their normal conformations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.108: Various chaperone molecules within the endoplasmic reticulum serve a "quality control" function, and appear to target the receptors for intracellular degradation, resulting in inefficient transport to the plasma membrane (39, 44, 45). 

Phrase: "Various chaperone molecules within the endoplasmic reticulum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0567416:molecules [Substance]
   732   C0243041:Molecular Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "serve"

Phrase: "a ""quality control"" function,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C2587213:Control function [Functional Concept]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "the receptors for intracellular degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1819635:receptor degradation [Molecular Function]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "resulting in inefficient transport"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332294:Resulting in [Functional Concept]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0231185:Inefficient [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "to the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(39,"

Phrase: "44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.109: Most class 2 mutations have been identified in the N-terminal half of the -subunit of the receptor (Fig. 6), but some mutations in the tyrosine kinase domain have also been reported to promote intracellular degradation (46). 

Phrase: "Most class 2 mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0441886:Class 2 [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "identified in the N-terminal half of the -subunit of the receptor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   736   C0205088:Terminal [Temporal Concept]
   736   C0205396:Identified [Qualitative Concept]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C1550043:Identified [Finding]
   736   C1551388:Identified [Functional Concept]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   736   C1711351:Subunit [Quantitative Concept]
   736   C2825407:Half [Quantitative Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "some mutations in the tyrosine kinase domain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "intracellular degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.110: View larger version (30K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.111: Mapping of mutations in the insulin receptor gene within the protein coding sequence of the complementary DNA. 

Phrase: "Mapping of mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1283195:Mapping [Activity]

Phrase: "in the insulin receptor gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1334133:Insulin Receptor Gene [Gene or Genome]
           INSULIN RECEPTOR
   913   C1337112:Insulin Gene [Gene or Genome]
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "within the protein coding sequence"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0079941:Protein Coding Sequence [Gene or Genome]
           Coding Sequence
   913   C0002518:Protein Sequence [Amino Acid Sequence]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "of the complementary DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.112: This figure depicts the regions of the insulin receptor that are the most common sites of missense mutations giving rise to the various classes of defects in receptor function.  

Phrase: "This figure"

Phrase: "depicts"

Phrase: "the regions of the insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "the most common sites of missense mutations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to the various classes of defects"

Phrase: "in receptor function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0920644:receptor function [Molecular Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.113: Class 3, decreased affinity of insulin binding.

Phrase: "Class 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441887:Class 3 [Intellectual Product]
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "decreased affinity of insulin binding."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.114: The N-terminal half of the -subunit has been implicated in the ligand binding domain of the insulin receptor and the homologous type 1 insulin-like growth factor receptor. 

Phrase: "The N-terminal half of the -subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2825407:Half [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the ligand binding domain of the insulin receptor"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   782   C0682969:Ligand Binding Domain [Amino Acid Sequence]
   777   C0597358:receptor ligand binding [Molecular Function]
           Receptor Binding
   777   C1149501:insulin receptor binding [Molecular Function]
   777   C1749413:insulin receptor ligand [Molecular Function]
   760   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   760   C1334133:INSULIN RECEPTOR [Gene or Genome]
   760   C1517880:Ligand Binding [Molecular Function]
   757   C1621296:receptor ligand [Molecular Function]
   757   C1623517:insulin binding [Molecular Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0023688:Ligand [Chemical]
   739   C0243122:binding [Functional Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the homologous type 1 insulin-like growth factor receptor."
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   890   C0140079:Insulin-Like Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   850   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   850   C1334133:INSULIN RECEPTOR [Gene or Genome]
   835   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441729:Type 1 [Classification]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0220844:growth [Physiologic Function]
   793   C0332307:Type [Qualitative Concept]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C1521761:Factor [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1547052:*Type [Quantitative Concept]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.115: Thus, it is not surprising that most of the mutations that inhibit insulin binding map to that domain of the receptor (Fig. 6) (8, 9, 10). 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "surprising"

Phrase: "that most of the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin binding map to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0024779:Map [Manufactured Object]
   770   C1706473:Map [Conceptual Entity]

Phrase: "that domain of the receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(8,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.116: In addition, at least two class 3 mutations have been mapped near the C-terminal domain of the -subunit. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "at least two class 3 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "mapped near the C-terminal domain of the -subunit."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C1707271:C-Terminal [Amino Acid Sequence]
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C1711351:Subunit [Quantitative Concept]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]
   708   C0024779:Map [Manufactured Object]
   708   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.117: Class 4, impaired receptor tyrosine kinase activity.

Phrase: "Class 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441888:Class 4 [Intellectual Product]
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "impaired receptor tyrosine kinase activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C1152633:receptor activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
Processing 00000000.tx.118: Most class 4 mutations are located in the tyrosine kinase domain in the intracellular portion of the -subunit (Fig. 6) (8, 9, 10). 

Phrase: "Most class 4 mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0441888:Class 4 [Intellectual Product]

Phrase: "are"

Phrase: "located in the tyrosine kinase domain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1519724:Tyrosine Kinase Domain [Amino Acid Sequence]
   790   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "in the intracellular portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "of the -subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711351:Subunit [Quantitative Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(8,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.119: However, mutations in the extracellular domain of the receptor have also been reported to uncouple insulin binding from the ability to activate the receptor tyrosine kinase (47). 

Phrase: "However,"

Phrase: "mutations in the extracellular domain of the receptor"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0684224:Reported [Intellectual Product]
   833   C0700287:Reported [Health Care Activity]
   833   C3496591:Reported [Clinical Attribute]
   799 E C3273238:Report [Intellectual Product]

Phrase: "uncouple"

Phrase: "insulin binding from the ability to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1623517:insulin binding [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the receptor tyrosine kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.120: Unlike most other classes of mutation, mutations in the kinase domain of the receptor exert a dominant negative effect to cause insulin resistance (48, 49). 

Phrase: "Unlike most"

Phrase: "other classes of mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]

Phrase: "mutations in the kinase domain of the receptor"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a dominant negative effect to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1280500:Effect [Qualitative Concept]
   812   C2348382:Effect [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.121: The resulting dominant inheritance pattern may be explained as follows: formation of hybrid receptors (i.e. association of a mutant -dimer to a mutant mutant-dimer) leads to the formation of a catalytically inactive 2mutant-tetramer. 

Phrase: "The resulting dominant inheritance pattern"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1136375:Pattern, Inheritance [Genetic Function]
   812   C0449774:Pattern [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "explained"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "formation of hybrid receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1819634:receptor formation [Molecular Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "(i.e. association of a mutant -dimer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "to a mutant mutant-dimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596448:dimer [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "leads to the formation of a catalytically inactive 2mutant-tetramer."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   739   C0039686:Tetramere [Eukaryote]
   739   C0181586:leads [Medical Device]
   739   C0205254:Inactive [Qualitative Concept]
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   739   C1522492:Formation [Functional Concept]
   739   C1522538:Lead [Functional Concept]
   739   C2348269:Lead [Element, Ion, or Isotope]
   739   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.122: Thus, in addition to being inactive itself, the mutant receptor inhibit the activity of wild type receptors. 

Phrase: "Thus,"

Phrase: "in addition to"

Phrase: "being"

Phrase: "inactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205254:Inactive [Qualitative Concept]

Phrase: "itself,"

Phrase: "the mutant receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the activity of wild type receptors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0459205:Type of activity [Intellectual Product]
   767   C1152633:receptor activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.123: Class 5, accelerated degradation of the receptor.

Phrase: "Class 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0457166:Class 5 [Intellectual Product]
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "accelerated degradation of the receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1819635:receptor degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.124: This is the least common class of mutations, with only two mutant alleles having been reported to accelerate degradation of receptors after having been inserted in the plasma membrane (50, 51). 

Phrase: "This"

Phrase: "is"

Phrase: "the least common class of mutations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456387:Class [Intellectual Product]
   753   C1705943:Class [Classification]

Phrase: "with only two mutant alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "having"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "degradation of receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C1819635:receptor degradation [Molecular Function]
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "after"

Phrase: "having"

Phrase: "been"

Phrase: "inserted in the plasma membrane"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0441587:Inserted [Health Care Activity]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "(50,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.125: Both of these mutations are located near the middle of the -subunit: Lys460Glu (36, 50) and Asn462Ser (38, 51). 

Phrase: "Both of these mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0026882:Mutations [Genetic Function]
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "located near the middle of the -subunit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0444598:Middle [Spatial Concept]
   748   C0549183:middle [Spatial Concept]
   748   C1552826:middle [Idea or Concept]
   748   C1711351:Subunit [Quantitative Concept]

Phrase: ":"

Phrase: "Lys460Glu"

Phrase: "(36,"

Phrase: "50"

Phrase: ")"

Phrase: "and"

Phrase: "Asn462Ser"

Phrase: "(38,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.126: In other words, although there seems not to be an intrinsic defect in the ability of these mutant receptors to mediate insulin action. 

Phrase: "In other words,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C1705313:Word [Idea or Concept]
   928 E C0439824:Verbal [Qualitative Concept]
   900 E C0871946:verb [Intellectual Product]

Phrase: "although"

Phrase: "there"

Phrase: "seems"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "an intrinsic defect in the ability of these mutant receptors to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1457869:Defect [Functional Concept]
   738   C1861101:DEFECT [Disease or Syndrome]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "insulin action."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.127: Accelerated degradation of mutant receptors leads to a marked decrease in the number of receptors expressed on the plasma membrane. 

Phrase: "Accelerated degradation of mutant receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1819635:receptor degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "leads to a marked decrease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0522501:Marked [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1706089:Marked [Qualitative Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "expressed on the plasma membrane."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.128: The impairment in the ability of the acid pH within endosomes to dissociate insulin from the receptor is associated with accelerated receptor degradation (36, 50, 52). 

Phrase: "The impairment in the ability of the acid pH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0684336:Impairment [Pathologic Function]

Phrase: "within endosomes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "dissociate"

Phrase: "insulin from the receptor"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   819   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   819   C1334133:INSULIN RECEPTOR [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "is"

Phrase: "associated with accelerated receptor degradation"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1819635:receptor degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0521110:Accelerated [Functional Concept]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0699900:Degradation [Organism Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(36,"

Phrase: "50,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.129: Although the mechanism has not been elucidated, this change in pH sensitivity is associated with preferential sorting of internalized receptors away from the pathway for recycling to the plasma membrane and toward the pathway for lysosomal degradation.  

Phrase: "Although"

Phrase: "the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "elucidated"

Phrase: ","

Phrase: "this change in pH sensitivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "associated with preferential sorting of internalized receptors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0237886:Sorting [Mental Process]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   748   C0700314:sorting [Cell Function]
   748   C1947906:Sorting [Activity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "away from the pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "for recycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282114:Recycling [Human-caused Phenomenon or Process]

Phrase: "to the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and toward the pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1515981:And [Idea or Concept]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]

Phrase: "for lysosomal degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.130: Conclusion Top Introduction Insulin Deficiency Insulin Resistance Conclusion References  In the past, the term "juvenile diabetes" was used to refer to diabetes caused by autoimmune destruction of pancreatic  cells (now called type 1 diabetes). 

Phrase: "Conclusion Top Introduction Insulin Deficiency Insulin Resistance Conclusion"

Phrase: "References  In the past,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1444637:Past [Temporal Concept]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]

Phrase: "the term ""juvenile diabetes"""
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0011854:Juvenile Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C3146221:Juvenile [Age Group]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "refer to diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0205543:refer [Functional Concept]

Phrase: "caused by autoimmune destruction of pancreatic  cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0007634:Cells [Cell]
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C0443146:Autoimmune [Pathologic Function]
   748   C1261381:Destruction [Therapeutic or Preventive Procedure]
   748   C1948029:Destruction [Activity]
   748   C3282337:Cells [Cell]
   714   C0015127:cause [Functional Concept]
   714 E C1269647:Cell [Cell]
   714   C1524003:Cause [Conceptual Entity]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(now called type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0011854:Type 1 diabetes [Disease or Syndrome]
   853   C1320657:type diabetes [Finding]
   840   C0441729:Type 1 [Classification]
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0332307:Type [Qualitative Concept]
   804   C1547052:*Type [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.131: This term was discarded for a variety of reasons; 

Phrase: "This term"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1515273:Term [Temporal Concept]
  1000   C1705313:Term [Idea or Concept]
  1000   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "discarded for a variety of reasons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392360:reasons [Idea or Concept]
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.132: among them, the fact that there are multiple types of diabetes with onset in childhood. 

Phrase: "among them,"

Phrase: "the fact"

Phrase: "that there"

Phrase: "are"

Phrase: "multiple types of diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1320657:diabetes types [Finding]
   770   C0332307:Types [Qualitative Concept]
   737 E C1547052:*Type [Quantitative Concept]

Phrase: "with onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "in childhood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231335:Childhood [Temporal Concept]
Processing 00000000.tx.133: As emphasized in this brief review, clinicians had previously described numerous forms of early-onset diabetes, some of which seemed to follow simple Mendelian forms of inheritance. 

Phrase: "As"

Phrase: "emphasized in this brief review,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0282443:Review [Intellectual Product]
   760   C1282927:brief [Qualitative Concept]
   760   C1552617:Review [Idea or Concept]
   760   C1879313:Brief [Temporal Concept]

Phrase: "clinicians"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871685:clinicians [Professional or Occupational Group]
   966 E C1550470:clinician [Idea or Concept]

Phrase: "had"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "numerous forms of early-onset diabetes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "seemed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "simple Mendelian"

Phrase: "forms of inheritance."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0242538:Inheritance [Quantitative Concept]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C0728826:Inheritance [Functional Concept]
   790   C1522492:Form [Functional Concept]
Processing 00000000.tx.134: As a result of the incredible progress in molecular genetics in recent years, the genes responsible for 10 forms of diabetes have been identified. 

Phrase: "As a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of the incredible progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1272688:progress [Functional Concept]
   861   C1280477:Progress [Functional Concept]

Phrase: "in molecular genetics"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "in recent years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "responsible for 10 forms of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.135: These developments provide a paradigm for future progress toward the goal of using molecular medicine to diagnose specific forms of diabetes in the hope that this will lead to develop therapeutic approaches that are tailored to specific molecular defects. 

Phrase: "These developments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0243107:development [Physiologic Function]
   966   C0678723:Development [Organism Function]
   966   C1527148:Development [Functional Concept]
   916 E C0458003:Developmental [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a paradigm for future progress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681797:paradigm [Research Activity]

Phrase: "toward the goal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018017:Goal [Intellectual Product]
  1000   C1571704:Goal [Idea or Concept]

Phrase: "of"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "molecular medicine to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1513397:Molecular Medicine [Biomedical Occupation or Discipline]
   827   C0013227:Medicine, NOS [Pharmacologic Substance]
   827   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "diagnose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:diagnose [Finding]

Phrase: "specific forms of diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "in the hope"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0392347:Hope [Mental Process]
   900 E C3540843:Hopefulness [Mental Process]

Phrase: "that"

Phrase: "this"

Phrase: "will"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "therapeutic approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "tailored to specific molecular defects."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205369:Specific [Qualitative Concept]
   760   C0243067:defects [Functional Concept]
   760   C0402883:tailored [Professional or Occupational Group]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.136: In some cases, this may turn out to be gene replacement therapy, but it is also likely that the efficacies of specific drugs will be shown to correlate with the patients genotype. 

Phrase: "In some cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "this"

Phrase: "may"

Phrase: "turn out to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439787:Out [Spatial Concept]
   827   C0541749:turn [Finding]
   827   C0849355:Out [Qualitative Concept]
   827   C1709743:Turn [Spatial Concept]

Phrase: "be"

Phrase: "gene replacement therapy,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1304648:Gene replacement therapy [Molecular Biology Research Technique,Therapeutic or Preventive Procedure]
   913   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   901   C0872178:gene replacement [Therapeutic or Preventive Procedure]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "also likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the efficacies of specific drugs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0598333:drug efficacy [Qualitative Concept]
   726   C1280519:Efficacy [Qualitative Concept]
   726   C1707887:EFFICACY [Research Activity]

Phrase: "will"

Phrase: "be"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with the patients genotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017431:Genotype [Organism Attribute]
   760   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.137: Finally, molecular diagnosis holds the promise of diagnosing diabetes early in life, before the onset of overt diabetes. 

Phrase: "Finally,"

Phrase: "molecular diagnosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1513388:Molecular Diagnosis [Laboratory Procedure]
   861   C0011900:Diagnosis [Finding]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "holds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553387:Hold [Idea or Concept]
  1000   C1948035:Hold [Activity]

Phrase: "the promise of diagnosing diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1555307:promise [Idea or Concept]

Phrase: "early in life,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0376558:Life [Idea or Concept]
   827   C1279919:Early [Temporal Concept]
   743 E C0595998:lives [Finding]

Phrase: "before"

Phrase: "the onset of overt diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.138: This will facilitate early interventions designed to prevent diabetes. 

Phrase: "This"

Phrase: "will"

Phrase: "facilitate"

Phrase: "early interventions"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0242687:Interventions, Early [Health Care Activity]
   983 E C1964029:early intervention [Therapeutic or Preventive Procedure]
   861   C0886296:interventions [Health Care Activity]
   861   C1273869:Interventions [Health Care Activity]
   861   C2979881:Interventions [Clinical Attribute]
   861   C3542921:Interventions [Classification]
   827 E C1948041:Intervention [Therapeutic or Preventive Procedure]
   777 E C3274035:INTERVENTIONAL [Research Activity]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.139: This avenue of research has the potential to lead to significant advances that will benefit patients suffering from the disease. 

Phrase: "This avenue of research"

Phrase: "has"

Phrase: "the potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "lead to significant advances"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1546944:Significant [Qualitative Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   737   C0725066:Advance [Medical Device]

Phrase: "that"

Phrase: "will"

Phrase: "benefit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0814225:Benefit [Quantitative Concept]

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "suffering from the disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0683278:Suffering [Mental or Behavioral Dysfunction]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.140: Received September 20, 1999. 

Phrase: "Received September 20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1999."
Processing 00000000.tx.141: Accepted October 3, 1999.  

Phrase: "Accepted October 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1999."
Processing 00000000.tx.142: References Top Introduction Insulin Deficiency Insulin Resistance Conclusion References  Fajans SS, Bell GI, Bowden DW, et al. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Introduction Insulin Deficiency Insulin Resistance Conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1707478:Conclusion [Idea or Concept]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Fajans SS,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Bowden DW,"

Phrase: "et al."
Processing 00000000.tx.143: 1996 Maturity onset diabetes of the young (MODY). 

Phrase: "1996 Maturity onset diabetes of the young"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   946   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   946   C2984262:Maturity onset diabetes of the young [Functional Concept]
   814   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C0449989:Maturity [Qualitative Concept]
   748   C0700597:Maturity [Temporal Concept]

Phrase: "(MODY"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   910   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   910   C2984262:Maturity onset diabetes of the young [Functional Concept]
   804   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   778   C1320657:type diabetes [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.144: Diabet Med. 

Phrase: "Diabet Med."
Processing 00000000.tx.145: 13(Suppl 6):S90S95. 

Phrase: "13"

Phrase: "(Suppl 6"

Phrase: ")"

Phrase: ":"

Phrase: "S90S95."
Processing 00000000.tx.146: Yamagata K, Furuta H, Oda N, et al. 

Phrase: "Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Furuta H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Oda N,"

Phrase: "et al."
Processing 00000000.tx.147: 1996 Mutations in the hepatocyte nuclear factor-4 gene in maturity-onset diabetes of the young (MODY1). 

Phrase: "1996 Mutations in the hepatocyte nuclear factor-4 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0596611:gene mutations [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "of the young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "(MODY1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1852093:MODY1 [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.148: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.149: 384:458460.[CrossRef][Medline] Bell GI, Pilkis SJ, Weber IT, Polonsky KS. 

Phrase: "384"

Phrase: ":"

Phrase: "458460."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Pilkis SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Weber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "IT,"

Phrase: "Polonsky KS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]
Processing 00000000.tx.150: 1996 Glucokinase mutations, insulin secretion, and diabetes mellitus. 

Phrase: "1996 Glucokinase mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.151: Annu Rev Physiol. 

Phrase: "Annu Rev Physiol."
Processing 00000000.tx.152: 58:171186.[CrossRef][Medline] Yamagata K, Oda N, Kaisaki PJ, et al. 

Phrase: "58"

Phrase: ":"

Phrase: "171186."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Oda N,"

Phrase: "Kaisaki PJ,"

Phrase: "et al."
Processing 00000000.tx.153: 1996 Mutations in the hepatocyte nuclear factor-1 gene in maturity-onset diabetes of the young (MODY3). 

Phrase: "1996 Mutations in the hepatocyte nuclear factor-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0596611:gene mutations [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "of the young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "(MODY3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1838100:MODY3 [Disease or Syndrome]
  1000   C3273648:MODY3 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.154: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.155: 384:455458.[CrossRef][Medline] Stoffers D, Ferrer J, Clarke W, Habener J. 

Phrase: "384"

Phrase: ":"

Phrase: "455458."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stoffers D,"

Phrase: "Ferrer J,"

Phrase: "Clarke W,"

Phrase: "Habener J."
Processing 00000000.tx.156: 1997 Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. 

Phrase: "1997 Early-onset type-II diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   877   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   877   C2984301:Type II diabetes mellitus [Functional Concept]
   829   C1320657:type diabetes [Finding]
   818   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   818   C0441730:Type II [Classification]
   795   C0011847:Diabetes [Disease or Syndrome]
   795   C0332307:Type [Qualitative Concept]
   795   C1547052:*Type [Quantitative Concept]

Phrase: "(MODY4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1826562:MODY4 [Gene or Genome]
  1000   C1833382:MODY4 [Disease or Syndrome]

Phrase: ")"

Phrase: "linked to IPF1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1826562:IPF1 [Gene or Genome]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]
Processing 00000000.tx.157: Nat Genet. 

Phrase: "Nat Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.158: 17:138139.[Medline] Horikawa Y, Iwasaki N, Hara M, et al. 

Phrase: "17"

Phrase: ":"

Phrase: "138139."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horikawa Y,"

Phrase: "Iwasaki N,"

Phrase: "Hara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.159: 1997 Mutation in hepatocyte nuclear factor-1  gene (TCF2) associated with MODY. 

Phrase: "1997 Mutation in hepatocyte nuclear factor-1  gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0596611:Gene Mutation [Genetic Function]
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(TCF2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420636:TCF2 [Gene or Genome]
  1000   C2348633:TCF2 [Gene or Genome]

Phrase: ")"

Phrase: "associated with MODY."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   860   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   860   C2984262:Maturity onset diabetes of the young [Functional Concept]
   784   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1320657:type diabetes [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0332162:Onset [Qualitative Concept]
   742   C0332239:Young [Temporal Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0449989:Maturity [Qualitative Concept]
   742   C0700597:Maturity [Temporal Concept]
   742   C1547052:*Type [Quantitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.160: Nat Genet. 

Phrase: "Nat Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.161: 17:384385.[Medline] Taylor SI, Accili D, Cama A, et al. 

Phrase: "17"

Phrase: ":"

Phrase: "384385."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Taylor SI,"

Phrase: "Accili D,"

Phrase: "Cama A,"

Phrase: "et al."
Processing 00000000.tx.162: 1991 Unusual forms of insulin resistance. 

Phrase: "1991 Unusual forms of insulin resistance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]
Processing 00000000.tx.163: Annu Rev Med. 

Phrase: "Annu Rev Med."
Processing 00000000.tx.164: 42:373379.[CrossRef][Medline] Taylor SI. 

Phrase: "42"

Phrase: ":"

Phrase: "373379."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Taylor SI."
Processing 00000000.tx.165: 1992 Lilly Lecture: molecular mechanisms of insulin resistance. 

Phrase: "1992 Lilly Lecture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0376683:lecture [Intellectual Product]

Phrase: ":"

Phrase: "molecular mechanisms of insulin resistance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1522618:resistance mechanism [Clinical Attribute]
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.166: Lessons from patients with mutations in the insulin-receptor gene. 

Phrase: "Lessons from patients"

Phrase: "with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the insulin-receptor gene."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1334133:Insulin Receptor Gene [Gene or Genome]
           INSULIN RECEPTOR
   913   C1337112:Insulin Gene [Gene or Genome]
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
Processing 00000000.tx.167: Diabetes. 

Phrase: "Diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.168: 41:14731490.[Abstract] Taylor SI, Cama A, Accili D, et al. 

Phrase: "41"

Phrase: ":"

Phrase: "14731490."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Taylor SI,"

Phrase: "Cama A,"

Phrase: "Accili D,"

Phrase: "et al."
Processing 00000000.tx.169: 1992 Mutations in the insulin receptor gene. 

Phrase: "1992 Mutations in the insulin receptor gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.170: Endocr Rev. 

Phrase: "Endocr Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.171: 13:566595.[Medline] Taylor S, Accili D, Imai Y. 

Phrase: "13"

Phrase: ":"

Phrase: "566595."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Taylor S,"

Phrase: "Accili D,"

Phrase: "Imai Y."
Processing 00000000.tx.172: 1994 Insulin resistance and insulin deficiency: which is the primary cause of NIDDM? 

Phrase: "1994 Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: ":"

Phrase: "which"

Phrase: "is"

Phrase: "the primary cause of NIDDM?"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015127:cause [Functional Concept]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.173: Diabetes. 

Phrase: "Diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.174: 43:735740.[Medline] Froguel P, Zouali H, Vionnet N, et al. 

Phrase: "43"

Phrase: ":"

Phrase: "735740."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Froguel P,"

Phrase: "Zouali H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Vionnet N,"

Phrase: "et al."
Processing 00000000.tx.175: 1993 Familial hyperglycemia due to mutations in glucokinase: definition of a new subtype of non-insulin-dependent (type 2) diabetes mellitus. 

Phrase: "1993 Familial hyperglycemia due to mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "in glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: ":"

Phrase: "definition of a new subtype of non-insulin-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1550452:definition [Idea or Concept]
   742   C1704788:Definition [Conceptual Entity]
   742   C3539107:Definition [Intellectual Product]

Phrase: "(type 2) diabetes mellitus."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.176: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.177: 328:697702.[Abstract/Free FullText] Steiner DF, Tager HS, Chan SJ, et al. 

Phrase: "328"

Phrase: ":"

Phrase: "697702."

Phrase: "[Abstract/Free FullText"

Phrase: "] Steiner DF,"

Phrase: "Tager HS,"

Phrase: "Chan SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.178: 1990 Lessons learned from molecular biology of insulin-gene mutations. 

Phrase: "1990 Lessons"

Phrase: "learned from molecular biology of insulin-gene mutations."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   770   C0596611:gene mutations [Genetic Function]
   770   C1337112:Insulin Gene [Gene or Genome]
   744   C0005532:Biology [Biomedical Occupation or Discipline]
   744   C0017337:Gene [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0023185:learned [Mental Process]
   744   C0026882:Mutations [Genetic Function]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.179: Diabetes Care. 

Phrase: "Diabetes Care."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947933:Care [Activity]
Processing 00000000.tx.180: 13:600609.[Abstract] Ballinger S, Shoffner JM, Hedaya EV, et al. 

Phrase: "13"

Phrase: ":"

Phrase: "600609."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ballinger S,"

Phrase: "Shoffner JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Hedaya EV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014522:EV [Neoplastic Process]
   861   C0560135:eV [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.181: 1992 Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. 

Phrase: "1992 Maternally"

Phrase: "transmitted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242781:Transmitted [Pathologic Function]
  1000   C0332289:transmitted [Functional Concept]
  1000   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "deafness"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0011053:Deafness [Disease or Syndrome]
  1000   C0018772:deafness [Finding]
  1000   C0581883:Deafness [Disease or Syndrome]
   928 E C0525064:DEAF [Patient or Disabled Group]
   928 E C1547302:Deaf [Intellectual Product]

Phrase: "associated with a 10.4 kb mitochondrial DNA deletion."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0948051:mitochondrial dna deletion [Cell or Molecular Dysfunction]
   764   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1819717:mitochondrial DNA [Cell Component]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C1442161:Deletion [Cell or Molecular Dysfunction]
   742   C1511760:Deletion [Genetic Function]
   742   C1880274:Deletion [Activity]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.182: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.183: 1:1115. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1115."
Processing 00000000.tx.184: van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek W, et al. 

Phrase: "van den Ouweland JMW,"

Phrase: "Lemkes HHPJ,"

Phrase: "Ruitenbeek W,"

Phrase: "et al."
Processing 00000000.tx.185: 1992 Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. 

Phrase: "1992 Mutation in mitochondrial tRNALeu"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2315666:Mitochondrial mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(UUR"

Phrase: ")"

Phrase: "gene in a large pedigree"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1416798:LARGE gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]

Phrase: "with maternally transmitted type II diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   901   C2984301:Type II diabetes mellitus [Functional Concept]
   839   C1320657:type diabetes [Finding]
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0441730:Type II [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "deafness."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0011053:Deafness [Disease or Syndrome]
  1000   C0018772:deafness [Finding]
  1000   C0581883:Deafness [Disease or Syndrome]
   928 E C0525064:DEAF [Patient or Disabled Group]
   928 E C1547302:Deaf [Intellectual Product]
Processing 00000000.tx.186: Nat Genet. 

Phrase: "Nat Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.187: 1:368371.[Medline] Kadowaki T, Kadowaki H, Mori Y, et al. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "368371."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kadowaki T,"

Phrase: "Kadowaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mori Y,"

Phrase: "et al."
Processing 00000000.tx.188: 1994 A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. 

Phrase: "1994"

Phrase: "A subtype of diabetes mellitus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449560:Subtype [Classification]

Phrase: "associated with a mutation of mitochondrial DNA."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1819717:mitochondrial DNA [Cell Component]
   774   C2315666:Mitochondrial mutation [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0026882:Mutation [Genetic Function]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.189: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.190: 330:962968.[Abstract/Free FullText] Inoue H, Tanizawa Y, Wasson J, et al. 

Phrase: "330"

Phrase: ":"

Phrase: "962968."

Phrase: "[Abstract/Free FullText"

Phrase: "] Inoue H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tanizawa Y,"

Phrase: "Wasson J,"

Phrase: "et al."
Processing 00000000.tx.191: 1998 A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). 

Phrase: "1998"

Phrase: "A gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a transmembrane protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1167322:transmembrane [Cell Component]
   861   C2752508:transmembrane [Cell Component]

Phrase: "is"

Phrase: "mutated in patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "with diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "optic atrophy"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0029124:Optic Atrophy [Disease or Syndrome]
   861   C0015392:Optic [Body Part, Organ, or Organ Component]
   861   C0029144:optic [Occupation or Discipline]
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "(Wolfram syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043207:Wolfram Syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0041383:Wolfram [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.192: Nat Genet. 

Phrase: "Nat Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.193: 20:143148.[CrossRef][Medline] Matschinsky FM. 

Phrase: "20"

Phrase: ":"

Phrase: "143148."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matschinsky FM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]
Processing 00000000.tx.194: 1990 Glucokinase as glucose sensor and metabolic signal generator in pancreatic  cells and hepatocytes. 

Phrase: "1990 Glucokinase as glucose sensor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "and"

Phrase: "metabolic signal generator in pancreatic  cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0237638:Generator [Manufactured Object]

Phrase: "and"

Phrase: "hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.195: Diabetes. 

Phrase: "Diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.196: 39:647652.[Abstract] Matschinsky FM, Glaser B, Magnuson MA. 

Phrase: "39"

Phrase: ":"

Phrase: "647652."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Matschinsky FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Glaser B,"

Phrase: "Magnuson MA."
Processing 00000000.tx.197: 1998 Pancreatic -cell glucokinase: closing the gap between theoretical concepts and experimental realities. 

Phrase: "1998 Pancreatic -cell glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: ":"

Phrase: "closing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:closing [Functional Concept]

Phrase: "the gap between theoretical concepts"

Phrase: "and"

Phrase: "experimental realities."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0871222:realities [Idea or Concept]
   777 E C0237400:Real [Qualitative Concept]
   777 E C3272377:REAL [Intellectual Product]
Processing 00000000.tx.198: Diabetes. 

Phrase: "Diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.199: 47:307315.[Abstract] Glaser B, Kesavan P, Heyman M, et al. 

Phrase: "47"

Phrase: ":"

Phrase: "307315."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Glaser B,"

Phrase: "Kesavan P,"

Phrase: "Heyman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.200: 1998 Familial hyperinsulinism caused by an activating glucokinase mutation. 

Phrase: "1998 Familial hyperinsulinism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2931834:Hyperinsulinism, familial [Disease or Syndrome]
   827   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "caused by an activating glucokinase mutation."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0026882:Mutation [Genetic Function]
   753   C1415014:GLUCOKINASE [Gene or Genome]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   753   C1879547:activating [Activity]
   719   C0015127:cause [Functional Concept]
   719 E C1515877:Activate [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.201: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.202: 338:226230.[Free FullText] Terauchi Y, Sakura H, Yasuda K, et al. 

Phrase: "338"

Phrase: ":"

Phrase: "226230."

Phrase: "[Free FullText"

Phrase: "] Terauchi Y,"

Phrase: "Sakura H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yasuda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.203: 1995 Pancreatic -cell-specific targeted disruption of glucokinase gene. 

Phrase: "1995 Pancreatic -cell-specific targeted disruption of glucokinase gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.204: Diabetes mellitus due to defective insulin secretion to glucose. 

Phrase: "Diabetes mellitus due to defective insulin secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   748   C0011847:Diabetes [Disease or Syndrome]

Phrase: "to glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.205: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.206: 270:3025330256.[Abstract/Free FullText] Postic C, Shiota M, Niswende K, et al. 

Phrase: "270"

Phrase: ":"

Phrase: "3025330256."

Phrase: "[Abstract/Free FullText"

Phrase: "] Postic C,"

Phrase: "Shiota M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Niswende K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.207: 1999 Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic  cell-specific gene knock-outs using Cre recombinase. 

Phrase: "1999 Dual roles for glucokinase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "in glucose homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326961:glucose homeostasis [Physiologic Function]
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "as"

Phrase: "determined by liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C2346688:LIVER [Food]
   734 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "pancreatic  cell-specific gene knock-outs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0599772:Outs, Gene Knock [Molecular Biology Research Technique]
   793   C0560617:knock out [Injury or Poisoning]
   793   C1522225:Knock-out [Experimental Model of Disease]
   766   C0439787:Out [Spatial Concept]
   766   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Cre recombinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1744318:Cre recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.208: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.209: 274:305315.[Abstract/Free FullText] Habener J, Stoffers D. 

Phrase: "274"

Phrase: ":"

Phrase: "305315."

Phrase: "[Abstract/Free FullText"

Phrase: "] Habener J,"

Phrase: "Stoffers D."
Processing 00000000.tx.210: 1998 A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. 

Phrase: "1998"

Phrase: "A newly discovered role of transcription factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "involved in pancreas development"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1523495:pancreas development [Biologic Function]
   770   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   770   C1314939:Involved [Functional Concept]
   770   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "the pathogenesis of diabetes mellitus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.211: Proc Assoc Am Physicians. 

Phrase: "Proc Assoc"

Phrase: "Am"

Phrase: "Physicians."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031831:Physicians [Professional or Occupational Group]
   966 E C0804815:Physician [Clinical Attribute]
Processing 00000000.tx.212: 110:1221.[Medline] Stoffers DA, Zinkin NT, Stanojevic V, et al. 

Phrase: "110"

Phrase: ":"

Phrase: "1221."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stoffers DA,"

Phrase: "Zinkin NT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: "Stanojevic V,"

Phrase: "et al."
Processing 00000000.tx.213: 1997 Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. 

Phrase: "1997 Pancreatic agenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0000846:Agenesis [Functional Concept]
   827   C0332907:Agenesis [Congenital Abnormality]

Phrase: "attributable to a single nucleotide deletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596130:Attributable [Mental Process]

Phrase: "in the human IPF1 gene coding sequence."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   840   C0079941:Coding Sequence [Gene or Genome]
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0009219:Coding [Occupational Activity]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   771 E C0805701:Code [Intellectual Product]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.214: Nat Genet. 

Phrase: "Nat Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.215: 15:106110.[Medline] Taylor SI, Dons RF, Hernandez E, et al. 

Phrase: "15"

Phrase: ":"

Phrase: "106110."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Taylor SI,"

Phrase: "Dons RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Hernandez E,"

Phrase: "et al."
Processing 00000000.tx.216: 1982 Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor. 

Phrase: "1982 Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "associated with androgen excess"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0235461:Androgen excess [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0002844:Androgen [Hormone,Pharmacologic Substance]
   770   C1979886:Excess [Qualitative Concept]
   770   C3536949:Androgen [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "with autoantibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "to the insulin receptor."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.217: Ann Intern Med. 

Phrase: "Ann Intern Med."
Processing 00000000.tx.218: 97:851855.[Medline] Nestler JE, Jakubowicz DJ. 

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "851855."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nestler JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Jakubowicz DJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.219: 1996 Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome (see comments). 

Phrase: "1996 Decreases in ovarian cytochrome P450c17 alpha activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0547047:decreases [Quantitative Concept]
   711 E C0392756:Decrease [Qualitative Concept]

Phrase: "and"

Phrase: "serum free testosterone after reduction of insulin secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0202228:Testosterone, Free [Laboratory Procedure]
   770   C0443483:Free testosterone [Hormone,Steroid]
   767   C0428413:Serum testosterone [Laboratory Procedure]
   767   C1515331:Testosterone Secretion [Organ or Tissue Function]
   744   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "in polycystic ovary syndrome"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032460:Polycystic Ovary Syndrome [Disease or Syndrome]
           Polycystic ovary
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0039082:Syndrome [Disease or Syndrome]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]
   827   C3273362:Polycystic [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282411:Comments [Intellectual Product]
  1000   C0947611:comments [Intellectual Product]
  1000   C1705247:Comments [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.220: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.221: 335:617623.[Abstract/Free FullText] Dunaif A, Scott D, Finegood D, et al. 

Phrase: "335"

Phrase: ":"

Phrase: "617623."

Phrase: "[Abstract/Free FullText"

Phrase: "] Dunaif A,"

Phrase: "Scott D,"

Phrase: "Finegood D,"

Phrase: "et al."
Processing 00000000.tx.222: 1996 The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. 

Phrase: "1996"

Phrase: "The insulin-sensitizing agent troglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "improves"

Phrase: "metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311400:Metabolic [Functional Concept]
  1000   C1524026:Metabolic [Cell Function]
  1000   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "reproductive abnormalities in the polycystic ovary syndrome."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0000768:Abnormalities [Congenital Abnormality]
   748   C0000769:abnormalities [Functional Concept]
   714 E C1704258:Abnormality [Finding]
Processing 00000000.tx.223: J Clin Endocrinol Metab. 

Phrase: "J Clin Endocrinol Metab."
Processing 00000000.tx.224: 81:32993306.[Abstract] Kahn CR, Flier JS, Bar RS, et al. 

Phrase: "81"

Phrase: ":"

Phrase: "32993306."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kahn CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Flier JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Bar RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.225: 1976 The syndromes of insulin resistance and acanthosis nigricans. 

Phrase: "1976"

Phrase: "The syndromes of insulin resistance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0021655:Insulin resistance syndrome [Pathologic Function]
   827   C0524620:Insulin resistance syndrome [Disease or Syndrome]
   790   C1857276:THE SYNDROME [Disease or Syndrome]
   760   C0039082:Syndromes [Disease or Syndrome]
   760   C1558916:SYNDROMES [Finding]

Phrase: "and"

Phrase: "acanthosis nigricans."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0000889:Acanthosis Nigricans [Disease or Syndrome]
   861   C0221270:Acanthosis [Pathologic Function]
   789 E C0333991:Acanthotic [Functional Concept]
Processing 00000000.tx.226: Insulin-receptor disorders in man. 

Phrase: "Insulin-receptor disorders in man."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.227: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.228: 294:739745.[Abstract] Donohue WL, Uchida I. 

Phrase: "294"

Phrase: ":"

Phrase: "739745."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Donohue WL,"

Phrase: "Uchida I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.229: 1954 Leprechaunism: a euphuism for a rare familial disorder. 

Phrase: "1954 Leprechaunism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0265344:Leprechaunism [Disease or Syndrome]

Phrase: ":"

Phrase: "a euphuism for a rare familial disorder."
Processing 00000000.tx.230: J Pediatr. 

Phrase: "J"

Phrase: "Pediatr."
Processing 00000000.tx.231: 45:505519. 

Phrase: "45"

Phrase: ":"

Phrase: "505519."
Processing 00000000.tx.232: Elders M, Schedewie H, Olefsky J, et al. 

Phrase: "Elders M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schedewie H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Olefsky J,"

Phrase: "et al."
Processing 00000000.tx.233: 1982 Endocrine-metabolic relationships in patients with leprechaunism. 

Phrase: "1982 Endocrine-metabolic relationships in patients"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0439849:Relationships [Qualitative Concept]
   719 E C1705630:Relationship [Idea or Concept]
   719 E C1706279:Relationship [Idea or Concept]
   719 E C3540605:Relationship [Intellectual Product]

Phrase: "with leprechaunism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0265344:Leprechaunism [Disease or Syndrome]
Processing 00000000.tx.234: J Natl Med Assoc. 

Phrase: "J Natl Med Assoc."
Processing 00000000.tx.235: 74:11951210.[Medline] Rosenberg AM, Haworth JC, Degroot GW, et al. 

Phrase: "74"

Phrase: ":"

Phrase: "11951210."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rosenberg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "AM"

Phrase: ","

Phrase: "Haworth JC,"

Phrase: "Degroot GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.236: 1980 A case of leprechaunism with severe hyperinsulinemia. 

Phrase: "1980"

Phrase: "A case of leprechaunism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]

Phrase: "with severe hyperinsulinemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020459:Hyperinsulinaemia [Disease or Syndrome]
Processing 00000000.tx.237: Am J Dis Child. 

Phrase: "Am"

Phrase: "J Dis Child."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008059:Child [Age Group]
   827   C0680063:CHILD [Family Group]
Processing 00000000.tx.238: 134:170175.[Abstract] Rabson SM, Mendenhall EN. 

Phrase: "134"

Phrase: ":"

Phrase: "170175."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rabson SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Mendenhall EN."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417861:eN [Gene or Genome]
   861   C2987294:EN [Qualitative Concept]
Processing 00000000.tx.239: 1956 Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus. 

Phrase: "1956 Familial hypertrophy of pineal body,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1849794:Pineal hypertrophy [Finding]
   753   C0020564:Hypertrophy [Pathologic Function]

Phrase: "hyperplasia of adrenal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0342494:Hyperplasia of Adrenal Cortex [Disease or Syndrome]
           ADRENAL CORTEX HYPERPLASIA
   819   C0001627:Adrenal Hyperplasia [Congenital Abnormality,Disease or Syndrome]
   819   C0342492:adrenal hyperplasia [Disease or Syndrome]
   819   C1621895:Adrenal hyperplasia [Disease or Syndrome]
   770   C0020507:Hyperplasia [Pathologic Function]

Phrase: "and"

Phrase: "diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.240: Am J Clin Pathol. 

Phrase: "Am"

Phrase: "J Clin Pathol."
Processing 00000000.tx.241: 26:283290.[Medline] Shimomura I, Hammer RE, Richardson JA, et al. 

Phrase: "26"

Phrase: ":"

Phrase: "283290."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimomura I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hammer RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Richardson JA,"

Phrase: "et al."
Processing 00000000.tx.242: 1998 Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. 

Phrase: "1998 Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes mellitus in transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   760   C0011847:Diabetes [Disease or Syndrome]

Phrase: "expressing"

Phrase: "nuclear SREBP-1c in adipose tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0537474:SREBP-1c [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420398:SREBP-1c [Gene or Genome]
   790   C3538602:SREBP-1c [Gene or Genome]

Phrase: ":"

Phrase: "model for congenital generalized lipodystrophy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.243: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.244: 12:31823194.[Abstract/Free FullText] Moitra J, Mason MM, Olive M, et al. 

Phrase: "12"

Phrase: ":"

Phrase: "31823194."

Phrase: "[Abstract/Free FullText"

Phrase: "] Moitra J,"

Phrase: "Mason MM,"

Phrase: "Olive M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.245: 1998 Life without white fat: a transgenic mouse. 

Phrase: "1998 Life without white fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0376558:Life [Idea or Concept]

Phrase: ":"

Phrase: "a transgenic mouse."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mouse, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
Processing 00000000.tx.246: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.247: 12:31683181.[Abstract/Free FullText] Garg A, Wilson R, Barnes R, et al. 

Phrase: "12"

Phrase: ":"

Phrase: "31683181."

Phrase: "[Abstract/Free FullText"

Phrase: "] Garg A,"

Phrase: "Wilson R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Barnes R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.248: 1999 A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. 

Phrase: "1999"

Phrase: "A gene for congenital generalized lipodystrophy maps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0079429:A Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]

Phrase: "to human chromosome 9q34."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1515529:9q34 [Cell Component]
   734   C0008643:Human Chromosome [Cell Component]
Processing 00000000.tx.249: J. 

Phrase: "J."
Processing 00000000.tx.250: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.251: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.252: Metab. 

Phrase: "Metab."
Processing 00000000.tx.253: 84:33903395. 

Phrase: "84"

Phrase: ":"

Phrase: "33903395."
Processing 00000000.tx.254: Peters JM, Barnes R, Bennett L, et al. 

Phrase: "Peters"

Phrase: "JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022337:JM [Geographic Area]

Phrase: "Barnes R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bennett L,"

Phrase: "et al."
Processing 00000000.tx.255: 1998 Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q2122. 

Phrase: "1998 Localization of the gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0008630:Gene Localization [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "for familial partial lipodystrophy"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0271694:Familial partial lipodystrophy [Disease or Syndrome]
   901   C0220989:Lipodystrophy, partial [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0023787:Lipodystrophy [Disease or Syndrome]
   827   C0241888:Familial [Functional Concept]
   827   C0728938:Partial [Quantitative Concept]
   827   C1550516:partial [Idea or Concept]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "(Dunnigan variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883525:Variety [Conceptual Entity]
   861   C2346866:Variety [Conceptual Entity]

Phrase: ")"

Phrase: "to chromosome 1q2122."
Processing 00000000.tx.256: Nat Genet. 

Phrase: "Nat Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.257: 18:292295.[CrossRef][Medline] Kadowaki T, Bevins CL, Cama A, et al. 

Phrase: "18"

Phrase: ":"

Phrase: "292295."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kadowaki T,"

Phrase: "Bevins CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Cama A,"

Phrase: "et al."
Processing 00000000.tx.258: 1988 Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. 

Phrase: "1988 Two mutant alleles of the insulin receptor gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Alleles [Gene or Genome]

Phrase: "in a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with extreme insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.259: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.260: 240:787790.[Medline] Kadowaki T, Kadowaki H, Taylor SI. 

Phrase: "240"

Phrase: ":"

Phrase: "787790."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kadowaki T,"

Phrase: "Kadowaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Taylor SI."
Processing 00000000.tx.261: 1990 A nonsense mutation causing decreased levels of insulin receptor mRNA: detection by a simplified technique for direct sequencing of genomic DNA amplified by the polymerase chain reaction. 

Phrase: "1990"

Phrase: "A nonsense mutation causing decreased levels of insulin receptor mRNA"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   764   C1295676:Decreased insulin level [Finding]
   757   C0202098:insulin levels [Laboratory Procedure]
   757   C0428405:insulin levels [Laboratory or Test Result]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: ":"

Phrase: "detection by a simplified technique"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "for direct sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "of genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "amplified by the polymerase chain reaction."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.262: Proc Natl Acad Sci USA. 

Phrase: "Proc Natl Acad Sci USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0041703:USA [Geographic Area]
Processing 00000000.tx.263: 87:658662.[Abstract] Kadowaki T, Kadowaki H, Rechler MM, et al. 

Phrase: "87"

Phrase: ":"

Phrase: "658662."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kadowaki T,"

Phrase: "Kadowaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Rechler MM,"

Phrase: "et al."
Processing 00000000.tx.264: 1990 Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance. 

Phrase: "1990 Five mutant alleles of the insulin receptor gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Alleles [Gene or Genome]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with genetic forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "of insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.265: J Clin Invest. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest."
Processing 00000000.tx.266: 86:254264.[Medline] Accili D, Frapier C, Mosthaf L, et al. 

Phrase: "86"

Phrase: ":"

Phrase: "254264."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Accili D,"

Phrase: "Frapier C,"

Phrase: "Mosthaf L,"

Phrase: "et al."
Processing 00000000.tx.267: 1989 A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin-resistant diabetes. 

Phrase: "1989"

Phrase: "A mutation in the insulin receptor gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "impairs"

Phrase: "transport of the receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "to the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "insulin-resistant diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0854110:Insulin resistant diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.268: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.269: 8:25092517.[Abstract] Cama A, Sierra ML, Ottini L, et al. 

Phrase: "8"

Phrase: ":"

Phrase: "25092517."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cama A,"

Phrase: "Sierra ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Ottini L,"

Phrase: "et al."
Processing 00000000.tx.270: 1991 A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. 

Phrase: "1991"

Phrase: "A mutation in the tyrosine kinase domain of the insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0026882:Mutation [Genetic Function]
   738   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in an obese woman."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Woman [Population Group]
Processing 00000000.tx.271: J Clin Endocrinol Metab. 

Phrase: "J Clin Endocrinol Metab."
Processing 00000000.tx.272: 73:894901.[Abstract] Cama A, Quon MJ, Sierra ML, Taylor SI. 

Phrase: "73"

Phrase: ":"

Phrase: "894901."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cama A,"

Phrase: "Quon MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Sierra ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Taylor SI."
Processing 00000000.tx.273: 1992 Substitution of isoleucine for methionine at position 1153 in the -subunit of the human insulin receptor. 

Phrase: "1992 Substitution of isoleucine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1555721:Substitution [Idea or Concept]
   770   C1706204:Substitution [Activity]

Phrase: "for methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "at position 1153"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "in the -subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711351:Subunit [Quantitative Concept]

Phrase: "of the human insulin receptor."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C1448132:insulin receptor, human [Amino Acid, Peptide, or Protein,Receptor]
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.274: A mutation that impairs receptor tyrosine kinase activity, receptor endocytosis, and insulin action. 

Phrase: "A mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "impairs"

Phrase: "receptor tyrosine kinase activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C1152633:receptor activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "receptor endocytosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014139:Endocytosis [Cell Function]
   861   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "insulin action."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.275: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.276: 267:83838389.[Abstract/Free FullText] Taylor SI. 

Phrase: "267"

Phrase: ":"

Phrase: "83838389."

Phrase: "[Abstract/Free FullText"

Phrase: "] Taylor SI."
Processing 00000000.tx.277: 1995 Prenatal screening for mutations in the insulin receptor gene. 

Phrase: "1995 Prenatal screening for mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0740178:Prenatal Screening [Therapeutic or Preventive Procedure]
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]

Phrase: "in the insulin receptor gene."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1334133:Insulin Receptor Gene [Gene or Genome]
           INSULIN RECEPTOR
   913   C1337112:Insulin Gene [Gene or Genome]
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
Processing 00000000.tx.278: How reliably does genotype predict phenotype? 

Phrase: "How reliably"

Phrase: "does"

Phrase: "genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "predict"

Phrase: "phenotype?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.279: J Clin Endocrinol Metab. 

Phrase: "J Clin Endocrinol Metab."
Processing 00000000.tx.280: 80:14931495.[Medline] Wertheimer E, Lu SP, Backeljauw PF, et al. 

Phrase: "80"

Phrase: ":"

Phrase: "14931495."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wertheimer E,"

Phrase: "Lu SP,"

Phrase: "Backeljauw PF,"

Phrase: "et al."
Processing 00000000.tx.281: 1993 Homozygous deletion of the human insulin receptor gene. 

Phrase: "1993 Homozygous deletion of the human insulin receptor gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0017260:Gene Deletion [Genetic Function]
   762   C1442161:Gene Deletion [Cell or Molecular Dysfunction]
           Deletion
   742   C1511760:Deletion [Genetic Function]
   742   C1880274:Deletion [Activity]
Processing 00000000.tx.282: Nat Genet. 

Phrase: "Nat Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.283: 5:7173.[Medline] Accili D, Kadowaki T, Kadowaki H, et al. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "7173."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Accili D,"

Phrase: "Kadowaki T,"

Phrase: "Kadowaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.284: 1992 Immunoglobulin heavy chain-binding protein binds to misfolded mutant insulin receptors with mutations in the extracellular domain. 

Phrase: "1992 Immunoglobulin heavy chain-binding protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   947   C0063423:immunoglobulin heavy chain-binding protein [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1415761:IMMUNOGLOBULIN HEAVY CHAIN-BINDING PROTEIN [Gene or Genome]
   885   C1412030:Immunoglobulin Binding Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1149306:immunoglobulin binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "binds to misfolded mutant insulin receptors"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   756 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the extracellular domain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1517050:Extracellular Domain [Spatial Concept]
   861   C0521119:Extracellular [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.285: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.286: 267:586590.[Abstract/Free FullText] Rouard M, Bass J, Grigorescu F, et al. 

Phrase: "267"

Phrase: ":"

Phrase: "586590."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rouard M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bass J,"

Phrase: "Grigorescu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.287: 1999 Congenital insulin resistance associated with a conformational alteration in a conserved -sheet in the insulin receptor L1 domain (In Process Citation). 

Phrase: "1999 Congenital insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   861   C0021655:Insulin Resistance [Pathologic Function]
   861   C2700570:INSULIN RESISTANCE [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0237834:Resistance [Mental Process]
   812   C1514892:Resistance [Physiologic Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   741 E C0332325:Resistant [Functional Concept]
   741 E C1550464:resistent [Idea or Concept]
   741 E C2827757:RESISTANT [Laboratory or Test Result]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "associated with a conformational alteration"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C1515926:Alteration [Idea or Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in a conserved -sheet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349187:Sheet [Quantitative Concept]

Phrase: "in the insulin receptor L1 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "(In Process Citation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0552371:Citation [Intellectual Product]
   734   C1550044:In Process [Idea or Concept]
   734   C1551390:In Process [Functional Concept]

Phrase: ")."
Processing 00000000.tx.288: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.289: 274:1848718491.[Abstract/Free FullText] Imamura T, Haruta T, Takata Y, et al. 

Phrase: "274"

Phrase: ":"

Phrase: "1848718491."

Phrase: "[Abstract/Free FullText"

Phrase: "] Imamura T,"

Phrase: "Haruta T,"

Phrase: "Takata Y,"

Phrase: "et al."
Processing 00000000.tx.290: 1998 Involvement of heat shock protein 90 in the degradation of mutant insulin receptors by the proteasome. 

Phrase: "1998 Involvement of heat shock protein 90"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in the degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "of mutant insulin receptors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   867 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.291: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.292: 273:1118311188.[Abstract/Free FullText] Accili D, Mosthaf L, Ullrich A, Taylor SI. 

Phrase: "273"

Phrase: ":"

Phrase: "1118311188."

Phrase: "[Abstract/Free FullText"

Phrase: "] Accili D,"

Phrase: "Mosthaf L,"

Phrase: "Ullrich A,"

Phrase: "Taylor SI."
Processing 00000000.tx.293: 1991 A mutation in the extracellular domain of the insulin receptor impairs the ability of insulin to stimulate receptor autophosphorylation. 

Phrase: "1991"

Phrase: "A mutation in the extracellular domain of the insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0026882:Mutation [Genetic Function]
   739   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "impairs"

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "stimulate"

Phrase: "receptor autophosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0813988:autophosphorylation [Molecular Function]
Processing 00000000.tx.294: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.295: 266:434439.[Abstract/Free FullText] Treadway JL, Morrison BD, Soos MA, et al. 

Phrase: "266"

Phrase: ":"

Phrase: "434439."

Phrase: "[Abstract/Free FullText"

Phrase: "] Treadway JL,"

Phrase: "Morrison BD,"

Phrase: "Soos MA,"

Phrase: "et al."
Processing 00000000.tx.296: 1991 Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. 

Phrase: "1991 Transdominant inhibition of tyrosine kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C2247121:inhibition of kinase activity [Molecular Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "in mutant insulin/insulin-like growth factor I hybrid receptors."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0140080:Receptors, Insulin-Like-Growth Factor I [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   894 E C1334088:INSULIN-LIKE GROWTH FACTOR I RECEPTOR [Gene or Genome]
   891   C0140079:Insulin-Like Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   879   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   862 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   846   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   791   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   708   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
Processing 00000000.tx.297: Proc Natl Acad Sci USA. 

Phrase: "Proc Natl Acad Sci USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0041703:USA [Geographic Area]
Processing 00000000.tx.298: 88:214218.[Abstract] Frattali AL, Treadway JL, Pessin JE. 

Phrase: "88"

Phrase: ":"

Phrase: "214218."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Frattali AL,"

Phrase: "Treadway JL,"

Phrase: "Pessin JE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]
Processing 00000000.tx.299: 1992 Insulin/IGF-1 hybrid receptors: implications for the dominant-negative phenotype in syndromes of insulin resistance. 

Phrase: "1992 Insulin/IGF-1 hybrid receptors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   876   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   867   C0140080:Receptors, IGF-1 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   859 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   841   C0140079:IGF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ":"

Phrase: "implications for the dominant-negative phenotype"

Phrase: "in syndromes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039082:Syndromes [Disease or Syndrome]
  1000   C1558916:SYNDROMES [Finding]

Phrase: "of insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.300: J Cell Biochem. 

Phrase: "J Cell Biochem."
Processing 00000000.tx.301: 48:4350.[Medline] Kadowaki H, Kadowaki T, Cama A, et al. 

Phrase: "48"

Phrase: ":"

Phrase: "4350."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kadowaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kadowaki T,"

Phrase: "Cama A,"

Phrase: "et al."
Processing 00000000.tx.302: 1990 Mutagenesis of lysine 460 in the human insulin receptor. 

Phrase: "1990 Mutagenesis of lysine 460"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079866:Mutagenesis [Molecular Function]
   760   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "in the human insulin receptor."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C1448132:insulin receptor, human [Amino Acid, Peptide, or Protein,Receptor]
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.303: Effects upon receptor recycling and cooperative interactions among binding sites. 

Phrase: "Effects upon receptor recycling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "cooperative interactions among binding sites."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.304: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.305: 265:2128521296.[Abstract/Free FullText] Cama A, Sierra ML, Kadowaki T, et al. 

Phrase: "265"

Phrase: ":"

Phrase: "2128521296."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cama A,"

Phrase: "Sierra ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Kadowaki T,"

Phrase: "et al."
Processing 00000000.tx.306: 1995 Two mutant alleles of the insulin receptor gene in a family with a genetic form of insulin resistance: a 10 base pair deletion in exon 1 and a mutation substituting serine for asparagine-462. 

Phrase: "1995 Two mutant alleles of the insulin receptor gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Alleles [Gene or Genome]

Phrase: "in a family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "with a genetic form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "of insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "a 10 base pair deletion in exon 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "a mutation substituting serine for asparagine-462."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.307: Hum Genet. 

Phrase: "Hum Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.308: 95:174182.[Medline] McElduff A, Hedo JA, Taylor SI, et al. 

Phrase: "95"

Phrase: ":"

Phrase: "174182."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McElduff A,"

Phrase: "Hedo JA,"

Phrase: "Taylor SI,"

Phrase: "et al."
Processing 00000000.tx.309: 1984 Insulin receptor degradation is accelerated in cultured lymphocytes from patients with genetic syndromes of extreme insulin resistance. 

Phrase: "1984 Insulin receptor degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C3547574:insulin degradation [Molecular Function]
   861   C1819635:receptor degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "accelerated in cultured lymphocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0024264:Lymphocytes [Cell]
   770   C0521110:Accelerated [Functional Concept]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with genetic syndromes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0567439:genetic syndromes [Disease or Syndrome]
   861   C0039082:Syndromes [Disease or Syndrome]
   861   C1558916:SYNDROMES [Finding]

Phrase: "of extreme insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.310: J Clin Invest. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest."
Processing 00000000.tx.311: 74:13661374.[Medline]

Phrase: "74"

Phrase: ":"

Phrase: "13661374."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

